	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
S145-PMC3208550	PMC3208550	11/2011	S145-PMC3208550	['C/Ebpα and C/Ebpβ in Adipose Tissue of nl and sl Rats\nCcaat/Enhancer-Binding Protein Α (C/Ebpα) HAS been shown to be a potent activator of the basal transcription of 11Β-Hsd1 WHEREAS Ccaat/Enhancer-Binding Protein Β (C/Ebpβ) is only a weak activator and competing with the strong activation of 11Β-Hsd1 Promoter activity mediated by C/Ebpα[30],[31], THEREFORE, the transcriptional activity of 11β-Hsd1 was assessed by the ratio of C/Ebpα to C/Ebpβ RATHER than measuring a single transcription factor alone.']	[('IMPORTANT_CONSIDERATION', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('PROBABLE_UNDERSTANDING', 350), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 448)]	4	[('PR_000003199', 'calcium/calmodulin-dependent protein kinase type II subunit alpha', 0, 'C/EBPα'), ('PR_000004967', 'calbindin', 11, 'C/EBPβ'), ('UBERON_0001013', 'adipose tissue', 21, 'adipose tissue'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 49, 'rats'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 54, 'CCAAT/enhancer-binding protein α'), ('SO_0000165', 'enhancer', 60, 'enhancer'), ('PR_000003199', 'calcium/calmodulin-dependent protein kinase type II subunit alpha', 88, 'C/EBPα'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 166, '11β-HSD1'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 183, 'CCAAT/enhancer-binding protein β'), ('SO_0000165', 'enhancer', 189, 'enhancer'), ('PR_000004967', 'calbindin', 217, 'C/EBPβ'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 294, '11β-HSD1'), ('SO_0000167', 'promoter', 303, 'promoter'), ('PR_000003199', 'calcium/calmodulin-dependent protein kinase type II subunit alpha', 333, 'C/EBPα'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 397, 'HSD1'), ('PR_000003199', 'calcium/calmodulin-dependent protein kinase type II subunit alpha', 431, 'C/EBPα'), ('PR_000004967', 'calbindin', 441, 'C/EBPβ')]
S102-PMC4806285	PMC4806285	3/2016	S102-PMC4806285	['for example, in vitro experiments INDICATE that the EFFECTS of stress/gc are mediated by Glycogen Synthase Kinase 3 (Gsk3) and Cyclin-Dependent Kinase 5 (Cdk5), both of which have WELL-ESTABLISHED ROLES in Tau hyperphosphorylation and the subsequent disruption of Microtubules, features SEEN in the ad Brain [82].']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 52), ('PROBABLE_UNDERSTANDING', 180), ('SUPERFICIAL_RELATIONSHIP', 197), ('INCOMPLETE_EVIDENCE', 287)]	5	[('CHEBI_24384', 'glycogens', 89, 'glycogen'), ('PR_000008081', 'guanine nucleotide-binding protein subunit alpha-12', 89, 'glycogen synthase kinase 3'), ('PR_000008288', 'glycogen synthase kinase-3 beta', 117, 'GSK3'), ('PR_000004911', 'complement component C9', 127, 'cyclin-dependent kinase'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 154, 'CDK5'), ('PR_000010173', 'microtubule-associated protein tau', 206, 'Tau'), ('GO_0005874', 'microtubule', 264, 'microtubules'), ('UBERON_0000955', 'brain', 302, 'brain')]
S118-PMC2682672	PMC2682672	6/2009	S118-PMC2682672	['Genetic variants at Cdkal1 and hhex-ide are ASSOCIATED with reduced Β-Cell function in Adults, and we HYPOTHESIZE that the ASSOCIATIONS with Birth weight are mediated via reduced fetal Insulin secretion.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 123)]	3	[('SO_0000704', 'gene', 0, 'Genetic'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 20, 'CDKAL1'), ('CL_0000623', 'natural killer cell', 68, 'β-cell'), ('UBERON_0007023', 'adult organism', 87, 'adults'), ('GO_0007567', 'parturition', 141, 'birth'), ('PR_000045358', 'insulin family protein', 185, 'insulin')]
S125-PMC2682672	PMC2682672	6/2009	S125-PMC2682672	['the ASSOCIATIONS of the Cdkal1 and hhex-ide variants with reduced Birth weight provide the FIRST direct EVIDENCE that common Genetic variation MAY account, IN PART, for the epidemiological ASSOCIATION between reduced Birth weight and type 2 diabetes.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 189)]	6	[('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 24, 'CDKAL1'), ('GO_0007567', 'parturition', 66, 'birth'), ('SO_0000704', 'gene', 125, 'genetic'), ('GO_0007567', 'parturition', 217, 'birth')]
S69-PMC3532199	PMC3532199	11/2012	S69-PMC3532199	['Genes that are good CANDIDATES for CONSIDERATION include mthfr, mthfd, mtr, Mtrr, Rfc1, Gcp2, Cbs, Bhmt, Bhmt2 and ts.']	[('INCOMPLETE_EVIDENCE', 20), ('FUTURE_WORK', 35)]	2	[('SO_0000704', 'gene', 0, 'Genes'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 76, 'MTRR'), ('PR_000013939', 'Ral-GDS-related protein', 82, 'RFC1'), ('PR_000007896', 'glucokinase regulatory protein', 88, 'GCP2'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 94, 'CBS'), ('PR_000004637', 'barrier-to-autointegration factor', 99, 'BHMT'), ('PR_000004633', 'brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1', 105, 'BHMT2')]
S130-PMC3877003	PMC3877003	12/2013	S130-PMC3877003	['at fdr 5% ONLY 15 Genes (hypergeometric probability\u200a=\u200a0.69) are found in both lists, of which 6 were down-regulated ( dym , Glrx2 , mlph , Myh10 , Pftk1 , and prep ) and 9 up-regulated ( Abcc8 , Abhd6 , Cep350 , ctsa , Eif2B3 , Pdk1 , serpina11 , Tpcn2 , and Tyw3 ).']	[('ANOMALY_CURIOUS_FINDING', 10), ('INCOMPLETE_EVIDENCE', 10)]	2	[('SO_0000704', 'gene', 18, 'genes'), ('PR_000008081', 'guanine nucleotide-binding protein subunit alpha-12', 124, 'Glrx2'), ('PR_000010911', 'lens fiber major intrinsic protein', 139, 'Myh10'), ('PR_000012764', 'piwi-like protein 3', 147, 'Pftk1'), ('PR_000003543', 'cholesterol transporter ABCA5', 187, 'Abcc8'), ('PR_000003573', 'ATP-binding cassette sub-family G member 8', 195, 'Abhd6'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 203, 'Cep350'), ('PR_000007270', 'exostosin-like 1', 219, 'Eif2b3'), ('PR_000012283', 'partitioning defective 6 homolog gamma', 228, 'Pdk1'), ('PR_000016593', 'tryptase gamma', 247, 'Tpcn2'), ('PR_000016870', 'thioredoxin-like protein 4B', 259, 'Tyw3')]
S171-PMC4208652	PMC4208652	6/2014	S171-PMC4208652	['C‐myc Regulates at least seven height‐associated Genes ( Cdk6, Coil, Hmga1, Lin28B, Rbbp8, Rps20, Trim25/efp ), and its binding to Genomic loci is DEPENDENT on Chromatin structure and Cpg Methylation.']	[('SUPERFICIAL_RELATIONSHIP', 147)]	1	[('PR_000005000', 'calmodulin-binding transcription activator 1', 0, 'c'), ('GO_0065007', 'biological regulation', 6, 'regulates'), ('SO_0000704', 'gene', 49, 'genes'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 57, 'CDK6'), ('PR_000005693', 'collagen alpha-1(X) chain', 63, 'COIL'), ('PR_000008608', 'hexokinase-1', 69, 'HMGA1'), ('PR_000009800', 'DNA ligase 1', 76, 'LIN28B'), ('PR_000013790', 'RNA-binding protein 25', 84, 'RBBP8'), ('PR_000014290', '40S ribosomal protein S7', 91, 'RPS20'), ('PR_000016662', 'tripartite motif-containing protein 55', 98, 'TRIM25'), ('SO_0001026', 'genome', 131, 'genomic'), ('GO_0000785', 'chromatin', 160, 'chromatin'), ('GO_0010424', 'DNA methylation on cytosine within a CG sequence', 184, 'CpG methylation')]
S218-PMC4208652	PMC4208652	6/2014	S218-PMC4208652	['Myc: metacore analysis REVEALED that the C‐Myc Regulates at least seven height‐associated Genes ( Cdk6, Coil, Hmga1, Lin28B, Rbbp8, Rps20 and Trim25/efp ).']	[('INCOMPLETE_EVIDENCE', 23)]	1	[('PR_000010878', 'myomesin-1', 0, 'MYC'), ('PR_000005009', 'calpain-1 catalytic subunit', 41, 'c‐Myc'), ('GO_0065007', 'biological regulation', 47, 'regulates'), ('SO_0000704', 'gene', 90, 'genes'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 98, 'CDK6'), ('PR_000005693', 'collagen alpha-1(X) chain', 104, 'COIL'), ('PR_000008608', 'hexokinase-1', 110, 'HMGA1'), ('PR_000009800', 'DNA ligase 1', 117, 'LIN28B'), ('PR_000013790', 'RNA-binding protein 25', 125, 'RBBP8'), ('PR_000014290', '40S ribosomal protein S7', 132, 'RPS20'), ('PR_000016662', 'tripartite motif-containing protein 55', 142, 'TRIM25')]
S146-PMC4663595	PMC4663595	11/2015	S146-PMC4663595	['SIMILARLY, an increase in mrna and protein Expression of the Ccaat/Enhancer-Binding Protein (C/Ebpb), a transcription factor that Regulates the Expression of Genes involved in Energy Homeostasis, was found to be altered in lp diet [58].']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('GO_0010467', 'gene expression', 43, 'expression'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 61, 'CCAAT/enhancer-binding protein'), ('SO_0000165', 'enhancer', 67, 'enhancer'), ('PR_000003199', 'calcium/calmodulin-dependent protein kinase type II subunit alpha', 93, 'C/EBPb'), ('GO_0065007', 'biological regulation', 130, 'regulates'), ('GO_0010467', 'gene expression', 144, 'expression'), ('SO_0000704', 'gene', 158, 'genes'), ('GO_0097009', 'energy homeostasis', 176, 'energy homeostasis')]
S239-PMC6039335	PMC6039335	7/2018	S239-PMC6039335	['the Expression of Adipogenic factors (Ccaat/Enhancer Binding Protein Beta, Ccaat/Enhancer Binding Protein Alpha, and Pparg) in the Subcutaneous Fat and imf was higher in the high-Concentrate group than that in the low-concentrate group, INDICATING that the dietary roughage/concentrate ratio AFFECTS Adipogenic Gene Expression in fat Tissues.']	[('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 292)]	2	[('GO_0010467', 'gene expression', 4, 'expression'), ('GO_0060612', 'adipose tissue development', 18, 'adipogenic'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 38, 'CCAAT/enhancer binding protein beta'), ('SO_0000165', 'enhancer', 44, 'enhancer'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 75, 'CCAAT/enhancer binding protein alpha'), ('SO_0000165', 'enhancer', 81, 'enhancer'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 117, 'PPARG'), ('UBERON_0002190', 'subcutaneous adipose tissue', 131, 'subcutaneous fat'), ('CHEBI_50913', 'fixative', 179, 'concentrate'), ('GO_0060612', 'adipose tissue development', 300, 'adipogenic'), ('GO_0010467', 'gene expression', 311, 'gene expression'), ('SO_0000704', 'gene', 311, 'gene'), ('UBERON_0000479', 'tissue', 334, 'tissues')]
S121-PMC4516488	PMC4516488	9/2009	S121-PMC4516488	['for APPROXIMATELY 40% of examined targets, changes measured by the Antibody microarray could BE reproduced by western blot, such as Cdk1/2, Egfr, pka, Akt3 and Pkcα.']	[('INCOMPLETE_EVIDENCE', 4), ('ANOMALY_CURIOUS_FINDING', 93)]	2	[('GO_0042571', 'immunoglobulin complex, circulating', 67, 'antibody'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 132, 'CDK1'), ('PR_000006900', 'erythroid differentiation-related factor 1', 140, 'EGFR'), ('PR_000003910', 'aflatoxin B1 aldehyde reductase member 4', 151, 'Akt3'), ('PR_000003059', 'protein kinase C beta type', 160, 'PKCα')]
S362-PMC4448820	PMC4448820	5/2015	S362-PMC4448820	['Rarα physically ASSOCIATES with the H3-K4 Histone Methyltransferase-5 (Mll5) and Promoter region of Ccaat/Enhancer Binding Protein Ε ( C/Ebpe ), enhancing Neutrophilic differentiation of the acute Promyelocytic leukemia cell line hl-60 (211).']	[('SUPERFICIAL_RELATIONSHIP', 16)]	1	[('PR_000013672', 'DNA repair protein RAD51 homolog 1', 0, 'RARα'), ('PR_000027547', 'histone H2A', 36, 'H3-K4'), ('CHEBI_15358', 'histone', 42, 'histone'), ('PR_000008479', 'polyamine deacetylase HDAC10', 42, 'histone methyltransferase-5'), ('PR_000010469', 'interstitial collagenase', 71, 'MLL5'), ('SO_0000167', 'promoter', 81, 'promoter'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 100, 'CCAAT/enhancer binding protein ε'), ('SO_0000165', 'enhancer', 106, 'enhancer'), ('PR_000003199', 'calcium/calmodulin-dependent protein kinase type II subunit alpha', 135, 'C/EBPe'), ('CL_0000775', 'neutrophil', 155, 'neutrophilic'), ('CL_0000836', 'promyelocyte', 197, 'promyelocytic')]
S297-PMC5187359	PMC5187359	12/2016	S297-PMC5187359	['the Hypothalamus is able to cross-talk to other Metabolically relevant Tissues such as Liver and Adipose Tissue through Sympathetic Circuits and circulating signals (leptin, Insulin, Cck, Neurotrophins, Il-6) by the Homeostatic Regulation Of the Endocannabinoid Signaling system (das,2010; maccarrone et al.,2014; seoane-collazo et al.,2015).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamus'), ('GO_0008152', 'metabolic process', 48, 'metabolically'), ('UBERON_0000479', 'tissue', 71, 'tissues'), ('UBERON_0002107', 'liver', 87, 'liver'), ('UBERON_0001013', 'adipose tissue', 97, 'adipose tissue'), ('UBERON_0003929', 'digestive tract epithelium', 120, 'sympathetic circuits'), ('PR_000045358', 'insulin family protein', 174, 'insulin'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 183, 'CCK'), ('PR_000021998', 'neurotrophin', 188, 'neurotrophins'), ('PR_000001470', 'interleukin-28B', 203, 'IL-6'), ('GO_0042592', 'homeostatic process', 216, 'homeostatic'), ('GO_0065007', 'biological regulation', 228, 'regulation of ...'), ('CHEBI_67198', 'retinoic acid receptor agonist', 246, 'endocannabinoid'), ('GO_0038002', 'endocrine signaling', 246, 'endocannabinoid signaling')]
S62-PMC3322122	PMC3322122	4/2012	S62-PMC3322122	['of Genes involvedgenes involved in pathway94 dpc vs. 1 dpnapran signalingup8.64*e-33cse1l, Ipo5, Kpna1Apigf1 signalingup3.97*e-26csnk2a1, Map2K1, Prkar2A, Raf1, Sos1, ywhagaporganisation of filamentsdown1.26*e-213b4galt7, bgn, cnp, Col1A2, Col2A1, Col5A1, Evl, Fgf2, Fnbp1, lox, Mtss1, Tgfb1, tnxbhppurine Metabolismup3.19*e-421adcy3, Atp13A2, Atp6V0B, bckdha, bckdhb, Entpd4, gmpr, itpa, Mad2L2, Nme1, Nme2, Nme3, Nudt2, Pold4, Polr1C, Polr2G, Polr2I, Polr2L, Psmc1, Rrm2B, ruvbl1hppyrimidine Metabolismup1.19*e-516entpd4, itpa, Mad2L2, Nme1, Nme2, Nme3, Nudt2, Pold4, Polr1C, Polr2G, Polr2I, Polr2L, Rpusd1, Rpusd2, Rpusd4, rrm2bhpoxidative phosphorylationup1.24*e-210atp6ap1, Atp6V0B, atp6v0e2, Cox6B1, Ndufa8, Ndufb7, Ndufb9, Ndufs3, Rpusd1, Tnni2Hpsynthesis and Degradation Of Ketone Bodiesup4.43*e-33acaa1, Acat2, bdh1hpglucocorticoid receptor signalingdown1.27*e-424ccl2, Fos, Gtf2E2, gtf2h3, Jun, Ncoa1, Ncoa2, Ncoa3, Ncor1, Pik3C3, Pik3R3, Polr2D, Ppp3Cb, Prkacb, Rras2, Serpine1, Shc1, Smad3, Stat1, Sumo1, tbp, Tgfb2, Tgfbr2, traf6hpcyclin and Cell Cycle Regulationdown8.09*e-512atr, Ccna2, Cdkn1B, E2F2, Hdac3, Hdac6, Ppp2Cb, Ppp2R1A, Ppp2R1B, Ppp2R5E, Rb1, Tgfb2Hpg1/s Checkpoint Regulationdown1.86*e-38atr, Cdkn1B, E2F2, Hdac3, Hdac6, Rb1, Smad3, tgfb2hpgrowth Hormone Signalingdown1,71*e-39fos, ghr, Igf1, Igfbp3, Pik3C3, Pik3R3, Rps6Ka3, Rps6Ka5, Stat1Hpmitotic roles of Polo-Like Kinasedown3.51*e-26cdc27, Plk4, Ppp2Cb, Ppp2R1A, Ppp2R1B, Ppp2R5Ehpigf1 signalingdown8.90*e-513fos, Igf1, Igfbp3, Igfbp5, Jun, Pik3C3, Pik3R3, Prkacb, Ptpn11, Rras2, Shc1, Ywhab, Ywhae1 dpn vs. 28 dpnappurine Metabolismup7.50*e-321Acin1, Atp11B, Atp13A2, Atp5G2, atp6v0b, Chrac1, Cilp, Ddx19B, dguok, Nme3, Pde2A, Pde5A, Polg, Polr2D, Polr2E, Polr2F, Polr2J, Polr3K, Prpsap2, Psmc5, Rfc3Appyrimidine Metabolismup5.95*e-313Chrac1, Ctps2, Nme3, Polg, Polr2D, Polr2E, Polr2F, Polr2J, Polr3K, Rfc3, Rpusd1, Rpusd4, uck1aporganisation of filamentsup5.74*e-312Akap2, Col1A1, Col1A2, Col5A2, Cryaa, Dbn1, Dcn, Fn1, Fnbp1, Pdlim3D, Serpinh1, Tgfb1Apfatty acid elongation in Mitochondriadown4.39*e-45acaa2, auh, hadh, Hsd17B4, pecrapran signalingdown2.49*e-23ipo5, Ran, xpo1apoxidative phosphorylationdown1.54*e-925Atp5B, Atp5C1, Atp5F1, Atp5J, atp6v1a, Atp6V1B2, Atp6V1C1, atp6v1h, Cox15, Cox17, Cox6C, Cox7C, Ndufa1, Ndufa9, Ndufab1, Ndufb1, Ndufb3, Ndufb5,Ndufc1, Ndufs2, Ndufv2, Ppa2, Sdha, Uqcr11, Uqcrbhpg2/m Dna Damage Checkpoint Regulationup2.63*e-48atr, Ccnb1, Ccnb2, Ptpmt1, Rprm, Wee1, ywhae, ywhaghpmitotic roles of Polo-Like Kinaseup4.95*e-49Anapc1, Anapc5, Ccnb1, Ccnb2, Plk4, Ppp2R3A, Pttg1, Stag2, wee1hpoxidative phosphorylationup2.23*e-314atp5a1, Atp5O, atp6v1a, atp6v1e1, Cox7B, Fam63B, Ip6K2, Ndufb6, Ndufs1, Ndufs4, ndufv2, Ppa1, Ppa2, Uhrf1Bp1Hpran signalingup2.88*e-34cse1l, Ipo5, Tnpo1, xpo1hporganisation of filamentsdown1.46*e-316Arhgef2, bgn, Col1A1, Col1A2, Col2A1, Col5A1, Dbn1, Dcn, Evl, Fat1, fes, lox, Mark4, Numa1, Ppp1R9Ad, Sirpa28 dpn vs. 188 dpnapampk signalingup1.10*e-211Pik3R1, Ppp2Ca, Ppp2Cb, Ppp2R2A, Ppp2R5A, Ppp2R5E, Prkaa1, Prkaa2, Prkab2, Prkacb, smarca2apmitotic roles of Polo-Like Kinaseup1.56*e-38Anapc11, Hsp90Aa1, Ppp2Ca, Ppp2Cb, Ppp2R2A, Ppp2R5A, Ppp2R5E, Stag2Apmtor Signalingup9.70*e-414eif3a, Eif4B, Napepld, Pik3R1, Ppp2Ca, Ppp2Cb, Ppp2R2A, Ppp2R5A, Ppp2R5E, Prkaa1, Prkaa2, Prkab2, rhoq, rictorapcyclin and cell Cycle Regulationup6.40*e-410atr, Gsk3B, Hdac2, Ppp2Ca, Ppp2Cb, Ppp2R2A, Ppp2R5A, Ppp2R5E, Raf1, tgfb2hppurine Metabolismup8.46*e-320Ampd3, Atf7Ip, Atp6V0E1, Atp6V1G2, Ddx19B, Eif2Ak4, Mad2L2, Mpp1, Nme6, Nt5C3, Polg, Polr1A, Polr2C, Polr2F, Ppat, Psmc1, Psmc3, Psmc5, Rfc3, vcphppyrimidine Metabolismup2.36*e-211Cmpk1, Eif2Ak4, Mad2L2, Nme6, Nt5C3, Nxn, Polg, Polr1A, Polr2C, Polr2F, rfc3hpglucocorticoid Receptor Signalingup2.13*e-216a2m, agt, Cxcl3, Ep300, Hsp90Aa1, Map3K14, Ncoa2, Ncor2, Nr3C1, Pik3C3, Polr2C, Polr2F, Smad3, Stat5B, tat, tsc22d3hpoxidative phosphorylationdown1.35*e-314cox15, Cox6A1, Cox7C, Ip6K2, Ndufa2, Ndufb3, Ndufb5, Ndufb6, Ndufb10, Ndufs3, Ndufs4, Ndufs6, Ppa2, uqcrbhpmitotic roles of Polo-Like Kinasedown2.30*e-26Ccnb2, Cdk1, Plk4, Prc1, Pttg1, Wee1Hpg2/m Dna Damage Checkpoint Regulationdown2.25*e-25Ccnb2, Cdk1, Cks1B, Wee1, ywhaz\nup and down indicate higher and lower abundance in later compared to earlier stages, respectively.']	N/A	N/A	[('SO_0000704', 'gene', 3, 'genes'), ('PR_000009089', 'importin-7', 91, 'IPO5'), ('PR_000009502', 'keratin, type II cuticular Hb6', 97, 'KPNA1APIGF1'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 138, 'MAP2K1'), ('PR_000013283', 'U4/U6 small nuclear ribonucleoprotein Prp4', 146, 'PRKAR2A'), ('PR_000013739', 'retinoic acid receptor responder protein 1', 155, 'RAF1'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 161, 'SOS1'), ('PR_000003266', 'collagen type II alpha chain', 232, 'COL1A2'), ('PR_000005703', 'collagen alpha-1(XIX) chain', 240, 'COL2A1'), ('PR_000003266', 'collagen type II alpha chain', 248, 'COL5A1'), ('PR_000007120', 'ephrin type-A receptor 1', 256, 'EVL'), ('PR_000007483', 'fibroblast growth factor 13', 261, 'FGF2'), ('PR_000007583', 'ketosamine-3-kinase', 267, 'FNBP1'), ('PR_000010755', 'metaxin-1', 279, 'MTSS1'), ('PR_000000046', 'TGF-beta', 286, 'TGFB1'), ('GO_0008152', 'metabolic process', 306, 'metabolismup3'), ('PR_000004479', 'V-type proton ATPase subunit e 2', 335, 'ATP13A2'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 344, 'ATP6V0B'), ('PR_000007070', 'homeobox protein engrailed-1', 369, 'ENTPD4'), ('PR_000010040', 'mitotic spindle assembly checkpoint protein MAD2B', 389, 'MAD2L2'), ('PR_000011040', 'nuclear receptor coactivator 1', 397, 'NME1'), ('PR_000011040', 'nuclear receptor coactivator 1', 403, 'NME2'), ('PR_000011040', 'nuclear receptor coactivator 1', 409, 'NME3'), ('PR_000011469', 'high affinity nerve growth factor receptor', 415, 'NUDT2'), ('PR_000012939', 'RNA-binding protein PNO1', 422, 'POLD4'), ('PR_000012989', 'DNA-directed RNA polymerase II subunit RPB3', 429, 'POLR1C'), ('PR_000012989', 'DNA-directed RNA polymerase II subunit RPB3', 437, 'POLR2G'), ('PR_000012970', 'DNA polymerase epsilon subunit 2', 445, 'POLR2I'), ('PR_000012980', 'DNA polymerase nu', 453, 'POLR2L'), ('PR_000013379', '26S proteasome regulatory subunit 7', 461, 'PSMC1'), ('PR_000014318', 'radical S-adenosyl methionine domain-containing protein 2', 468, 'RRM2B'), ('GO_0008152', 'metabolic process', 494, 'metabolismup1'), ('PR_000010040', 'mitotic spindle assembly checkpoint protein MAD2B', 530, 'MAD2L2'), ('PR_000011040', 'nuclear receptor coactivator 1', 538, 'NME1'), ('PR_000011040', 'nuclear receptor coactivator 1', 544, 'NME2'), ('PR_000011040', 'nuclear receptor coactivator 1', 550, 'NME3'), ('PR_000011469', 'high affinity nerve growth factor receptor', 556, 'NUDT2'), ('PR_000012939', 'RNA-binding protein PNO1', 563, 'POLD4'), ('PR_000012989', 'DNA-directed RNA polymerase II subunit RPB3', 570, 'POLR1C'), ('PR_000012989', 'DNA-directed RNA polymerase II subunit RPB3', 578, 'POLR2G'), ('PR_000012970', 'DNA polymerase epsilon subunit 2', 586, 'POLR2I'), ('PR_000012980', 'DNA polymerase nu', 594, 'POLR2L'), ('PR_000014339', 'radial spoke head 14 homolog', 602, 'RPUSD1'), ('PR_000014173', 'replication protein A 30 kDa subunit', 610, 'RPUSD2'), ('PR_000014173', 'replication protein A 30 kDa subunit', 618, 'RPUSD4'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 679, 'ATP6V0B'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 698, 'COX6B1'), ('PR_000011099', 'NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial', 706, 'NDUFA8'), ('PR_000011099', 'NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial', 714, 'NDUFB7'), ('PR_000011050', 'kinetochore protein NDC80', 722, 'NDUFB9'), ('PR_000011050', 'kinetochore protein NDC80', 730, 'NDUFS3'), ('PR_000014339', 'radial spoke head 14 homolog', 738, 'RPUSD1'), ('PR_000016473', 'tumor necrosis factor alpha-induced protein 2', 746, 'TNNI2HPSynthesis'), ('GO_0009600', 'detection of nematode', 767, 'degradation of ketone'), ('CHEBI_17087', 'ketone', 782, 'ketone'), ('PR_000004691', 'B-cell lymphoma/leukemia 11B', 789, 'bodiesup4'), ('PR_000003666', 'acyl-coenzyme A synthetase ACSM2B, mitochondrial', 813, 'ACAT2'), ('PR_000007593', 'glutamate carboxypeptidase 2', 879, 'FOS'), ('PR_000008322', 'general transcription factor II-I', 884, 'GTF2E2'), ('PR_000009211', 'lysine-specific demethylase 3A', 900, 'JUN'), ('PR_000011209', 'nidogen-2', 905, 'NCOA1'), ('PR_000011209', 'nidogen-2', 912, 'NCOA2'), ('PR_000011209', 'nidogen-2', 919, 'NCOA3'), ('PR_000011209', 'nidogen-2', 926, 'NCOR1'), ('PR_000012777', 'fibrocystin', 933, 'PIK3C3'), ('PR_000012727', 'phosphoinositide 3-kinase regulatory subunit 4', 941, 'PIK3R3'), ('PR_000012980', 'DNA polymerase nu', 949, 'POLR2D'), ('PR_000013133', 'neurabin-2', 957, 'PPP3CB'), ('PR_000013502', 'parvalbumin alpha', 965, 'PRKACB'), ('PR_000014318', 'radical S-adenosyl methionine domain-containing protein 2', 973, 'RRAS2'), ('PR_000014693', 'serpin B13', 980, 'SERPINE1'), ('PR_000000364', 'smad2', 990, 'SHC1'), ('PR_000000364', 'smad2', 996, 'SMAD3'), ('PR_000015700', 'alpha-2,8-sialyltransferase 8F', 1003, 'STAT1'), ('PR_000015829', 'small ubiquitin-related modifier 1', 1010, 'SUMO1'), ('PR_000000046', 'TGF-beta', 1022, 'TGFB2'), ('PR_000000183', 'TGF-beta 2', 1029, 'TGFBR2'), ('GO_0048469', 'cell maturation', 1055, 'cell cycle regulationdown8'), ('PR_000001202', 'C-C chemokine receptor type 6', 1095, 'CCNA2'), ('PR_000005259', 'cyclin-dependent kinase 5 activator 1', 1102, 'CDKN1B'), ('PR_000006853', 'transcription factor E2F2', 1110, 'E2F2'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 1116, 'HDAC3'), ('PR_000008488', 'histone deacetylase 9', 1123, 'HDAC6'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 1130, 'PPP2CB'), ('PR_000013133', 'neurabin-2', 1138, 'PPP2R1A'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 1147, 'PPP2R1B'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 1156, 'PPP2R5E'), ('PR_000013830', 'calcipressin-2', 1165, 'RB1'), ('PR_000000183', 'TGF-beta 2', 1170, 'TGFB2HPG1'), ('GO_0010031', 'circumnutation', 1182, 'checkpoint regulationdown1'), ('PR_000005259', 'cyclin-dependent kinase 5 activator 1', 1221, 'CDKN1B'), ('PR_000006853', 'transcription factor E2F2', 1229, 'E2F2'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 1235, 'HDAC3'), ('PR_000008488', 'histone deacetylase 9', 1242, 'HDAC6'), ('PR_000013830', 'calcipressin-2', 1249, 'RB1'), ('PR_000000364', 'smad2', 1254, 'SMAD3'), ('GO_0035852', 'horizontal cell localization', 1275, 'hormone signalingdown1'), ('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 1315, 'IGF1'), ('PR_000008940', 'intraflagellar transport protein 88', 1321, 'IGFBP3'), ('PR_000012777', 'fibrocystin', 1329, 'PIK3C3'), ('PR_000012727', 'phosphoinositide 3-kinase regulatory subunit 4', 1337, 'PIK3R3'), ('PR_000014290', '40S ribosomal protein S7', 1345, 'RPS6KA3'), ('PR_000014298', 'Ras-related GTP-binding protein B', 1354, 'RPS6KA5'), ('PR_000015699', 'alpha-2,8-sialyltransferase 8E', 1363, 'STAT1HPMitotic'), ('PR_000013439', 'prostate tumor-overexpressed gene 1 protein', 1387, 'Polo-like kinasedown3'), ('PR_000012888', 'phospholipid transfer protein', 1423, 'PLK4'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 1429, 'PPP2CB'), ('PR_000013133', 'neurabin-2', 1437, 'PPP2R1A'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 1446, 'PPP2R1B'), ('PR_000013444', 'very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3', 1455, 'PPP2R5EHPIGF1'), ('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 1497, 'IGF1'), ('PR_000008940', 'intraflagellar transport protein 88', 1503, 'IGFBP3'), ('PR_000008940', 'intraflagellar transport protein 88', 1511, 'IGFBP5'), ('PR_000009211', 'lysine-specific demethylase 3A', 1519, 'JUN'), ('PR_000012777', 'fibrocystin', 1524, 'PIK3C3'), ('PR_000012727', 'phosphoinositide 3-kinase regulatory subunit 4', 1532, 'PIK3R3'), ('PR_000013502', 'parvalbumin alpha', 1540, 'PRKACB'), ('PR_000013451', 'tyrosine-protein phosphatase non-receptor type 13', 1548, 'PTPN11'), ('PR_000014318', 'radical S-adenosyl methionine domain-containing protein 2', 1556, 'RRAS2'), ('PR_000000364', 'smad2', 1563, 'SHC1'), ('PR_000017539', 'synaptobrevin homolog YKT6', 1569, 'YWHAB'), ('PR_000017551', '14-3-3 protein eta', 1576, 'YWHAE1'), ('GO_0051238', 'sequestering of metal ion', 1606, 'metabolismup7'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1625, '321ACIN1'), ('PR_000029299', 'B-cell CLL/lymphoma 7 protein family member A', 1635, 'ATP11B'), ('PR_000004479', 'V-type proton ATPase subunit e 2', 1643, 'ATP13A2'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 1652, 'ATP5G2'), ('PR_000005438', 'charged multivesicular body protein 4c', 1669, 'CHRAC1'), ('PR_000005433', 'charged multivesicular body protein 1b', 1677, 'CILP'), ('PR_000029393', 'probable ATP-dependent RNA helicase DDX56', 1683, 'DDX19B'), ('PR_000011040', 'nuclear receptor coactivator 1', 1698, 'NME3'), ('PR_000012493', 'pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial', 1704, 'PDE2A'), ('PR_000012493', 'pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial', 1711, 'PDE5A'), ('PR_000012978', 'DNA polymerase lambda', 1718, 'POLG'), ('PR_000012980', 'DNA polymerase nu', 1724, 'POLR2D'), ('PR_000012980', 'DNA polymerase nu', 1732, 'POLR2E'), ('PR_000012980', 'DNA polymerase nu', 1740, 'POLR2F'), ('PR_000012980', 'DNA polymerase nu', 1748, 'POLR2J'), ('PR_000012980', 'DNA polymerase nu', 1756, 'POLR3K'), ('PR_000013271', 'protor-1', 1764, 'PRPSAP2'), ('PR_000013379', '26S proteasome regulatory subunit 7', 1773, 'PSMC5'), ('PR_000001245', 'rhodopsin', 1780, 'RFC3APPyrimidine'), ('GO_0015976', 'carbon utilization', 1797, 'metabolismup5'), ('PR_000011029', 'neurochondrin', 1816, '313CHRAC1'), ('PR_000006020', 'chymotrypsin-C', 1827, 'CTPS2'), ('PR_000011040', 'nuclear receptor coactivator 1', 1834, 'NME3'), ('PR_000012978', 'DNA polymerase lambda', 1840, 'POLG'), ('PR_000012980', 'DNA polymerase nu', 1846, 'POLR2D'), ('PR_000012980', 'DNA polymerase nu', 1854, 'POLR2E'), ('PR_000012980', 'DNA polymerase nu', 1862, 'POLR2F'), ('PR_000012980', 'DNA polymerase nu', 1870, 'POLR2J'), ('PR_000012980', 'DNA polymerase nu', 1878, 'POLR3K'), ('PR_000013900', 'DNA polymerase zeta catalytic subunit', 1886, 'RFC3'), ('PR_000014339', 'radial spoke head 14 homolog', 1892, 'RPUSD1'), ('PR_000014173', 'replication protein A 30 kDa subunit', 1900, 'RPUSD4'), ('PR_000008770', 'corticosteroid 11-beta-dehydrogenase isozyme 1', 1948, '312AKAP2'), ('PR_000003266', 'collagen type II alpha chain', 1958, 'COL1A1'), ('PR_000003266', 'collagen type II alpha chain', 1966, 'COL1A2'), ('PR_000005703', 'collagen alpha-1(XIX) chain', 1974, 'COL5A2'), ('PR_000005866', 'cAMP-responsive element modulator', 1982, 'CRYAA'), ('PR_000006317', 'mRNA-decapping enzyme 1A', 1989, 'DBN1'), ('PR_000006317', 'mRNA-decapping enzyme 1A', 1995, 'DCN'), ('PR_000007581', 'fibronectin', 2000, 'FN1'), ('PR_000007583', 'ketosamine-3-kinase', 2005, 'FNBP1'), ('PR_000012579', '6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2', 2012, 'PDLIM3D'), ('PR_000014690', 'serpin B10', 2021, 'SERPINH1'), ('PR_000021911', 'activin/inhibin beta A chain isoform 1, signal peptide removed form', 2031, 'TGFB1APFatty'), ('GO_0005739', 'mitochondrion', 2063, 'mitochondriadown4'), ('PR_000008760', 'heparan sulfate glucosamine 3-O-sulfotransferase 3A1', 2106, 'HSD17B4'), ('PR_000013739', 'retinoic acid receptor responder protein 1', 2153, 'RAN'), ('PR_000017506', 'DNA repair protein XRCC3', 2200, '925ATP5B'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 2210, 'ATP5C1'), ('PR_000004489', 'V-type proton ATPase subunit G 1', 2218, 'ATP5F1'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 2226, 'ATP5J'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 2242, 'ATP6V1B2'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 2252, 'ATP6V1C1'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 2271, 'COX15'), ('PR_000005773', 'cytochrome c oxidase copper chaperone', 2278, 'COX17'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 2285, 'COX6C'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 2292, 'COX7C'), ('PR_000011159', 'nexilin', 2299, 'NDUFA1'), ('PR_000011099', 'NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial', 2307, 'NDUFA9'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 2315, 'NDUFAB1'), ('PR_000011050', 'kinetochore protein NDC80', 2324, 'NDUFB1'), ('PR_000011050', 'kinetochore protein NDC80', 2332, 'NDUFB3'), ('PR_000011050', 'kinetochore protein NDC80', 2340, 'NDUFB5'), ('PR_000011050', 'kinetochore protein NDC80', 2347, 'NDUFC1'), ('PR_000011050', 'kinetochore protein NDC80', 2355, 'NDUFS2'), ('PR_000011050', 'kinetochore protein NDC80', 2363, 'NDUFV2'), ('PR_000013060', 'peroxisome proliferator-activated receptor gamma coactivator 1-beta', 2371, 'PPA2'), ('PR_000014460', 'serine--tRNA ligase, mitochondrial', 2377, 'SDHA'), ('PR_000017120', 'ubiquinol-cytochrome-c reductase complex assembly factor 1', 2383, 'UQCR11'), ('PR_000017112', 'uroplakin-1a', 2391, 'UQCRBHPG2'), ('GO_0000729', 'DNA double-strand break processing', 2403, 'DNA damage checkpoint regulationup2'), ('PR_000005155', 'T-complex protein 1 subunit zeta-2', 2451, 'CCNB1'), ('PR_000005155', 'T-complex protein 1 subunit zeta-2', 2458, 'CCNB2'), ('PR_000013441', 'protein tyrosine phosphatase type IVA 2', 2465, 'PTPMT1'), ('PR_000014190', '60S ribosomal protein L11', 2473, 'RPRM'), ('PR_000017405', 'WAP four-disulfide core domain protein 1', 2479, 'WEE1'), ('PR_000012733', 'serine/threonine-protein kinase Pim-2', 2516, 'Polo-like kinaseup4'), ('PR_000012509', 'PDZ and LIM domain protein 2', 2541, '49ANAPC1'), ('PR_000004051', 'ankyrin repeat and SAM domain-containing protein 1A', 2551, 'ANAPC5'), ('PR_000005155', 'T-complex protein 1 subunit zeta-2', 2559, 'CCNB1'), ('PR_000005155', 'T-complex protein 1 subunit zeta-2', 2566, 'CCNB2'), ('PR_000012888', 'phospholipid transfer protein', 2573, 'PLK4'), ('PR_000013133', 'neurabin-2', 2579, 'PPP2R3A'), ('PR_000013459', 'tyrosine-protein phosphatase non-receptor type 4', 2588, 'PTTG1'), ('PR_000015700', 'alpha-2,8-sialyltransferase 8F', 2595, 'STAG2'), ('PR_000004455', 'ATP synthase subunit gamma, mitochondrial', 2653, 'ATP5O'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 2679, 'COX7B'), ('PR_000029469', 'spermatogenesis-associated protein 31D1', 2686, 'FAM63B'), ('PR_000009089', 'importin-7', 2694, 'IP6K2'), ('PR_000011099', 'NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial', 2701, 'NDUFB6'), ('PR_000011159', 'nexilin', 2709, 'NDUFS1'), ('PR_000011159', 'nexilin', 2717, 'NDUFS4'), ('PR_000013060', 'peroxisome proliferator-activated receptor gamma coactivator 1-beta', 2733, 'PPA1'), ('PR_000013060', 'peroxisome proliferator-activated receptor gamma coactivator 1-beta', 2739, 'PPA2'), ('PR_000017022', 'UBX domain-containing protein 6', 2745, 'UHRF1BP1HPRAN'), ('PR_000009089', 'importin-7', 2786, 'IPO5'), ('PR_000016501', 'tenascin-N', 2792, 'TNPO1'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 2841, '316ARHGEF2'), ('PR_000003266', 'collagen type II alpha chain', 2858, 'COL1A1'), ('PR_000003266', 'collagen type II alpha chain', 2866, 'COL1A2'), ('PR_000005703', 'collagen alpha-1(XIX) chain', 2874, 'COL2A1'), ('PR_000003266', 'collagen type II alpha chain', 2882, 'COL5A1'), ('PR_000006317', 'mRNA-decapping enzyme 1A', 2890, 'DBN1'), ('PR_000006317', 'mRNA-decapping enzyme 1A', 2896, 'DCN'), ('PR_000007120', 'ephrin type-A receptor 1', 2901, 'EVL'), ('PR_000007319', 'fatty acid desaturase 3', 2906, 'FAT1'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 2922, 'MARK4'), ('PR_000011490', '8-oxo-dGDP phosphatase NUDT18', 2929, 'NUMA1'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 2936, 'PPP1R9AD'), ('PR_000014888', 'NAD-dependent protein deacetylase sirtuin-1', 2946, 'SIRPA28'), ('PR_000010977', 'nucleosome assembly protein 1-like 3', 2994, '211PIK3R1'), ('PR_000013090', 'protein phosphatase 1A', 3005, 'PPP2CA'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 3013, 'PPP2CB'), ('PR_000013133', 'neurabin-2', 3021, 'PPP2R2A'), ('PR_000013133', 'neurabin-2', 3030, 'PPP2R5A'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 3039, 'PPP2R5E'), ('PR_000013282', 'pre-mRNA-processing factor 39', 3048, 'PRKAA1'), ('PR_000013282', 'pre-mRNA-processing factor 39', 3056, 'PRKAA2'), ('PR_000013222', 'cAMP-dependent protein kinase catalytic subunit alpha', 3064, 'PRKAB2'), ('PR_000013502', 'parvalbumin alpha', 3072, 'PRKACB'), ('PR_000012733', 'serine/threonine-protein kinase Pim-2', 3106, 'Polo-like kinaseup1'), ('PR_000010980', 'Nck-associated protein 5', 3131, '38ANAPC11'), ('PR_000008812', 'heat shock cognate 71 kDa protein', 3142, 'HSP90AA1'), ('PR_000013090', 'protein phosphatase 1A', 3152, 'PPP2CA'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 3160, 'PPP2CB'), ('PR_000013133', 'neurabin-2', 3168, 'PPP2R2A'), ('PR_000013133', 'neurabin-2', 3177, 'PPP2R5A'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 3186, 'PPP2R5E'), ('PR_000015418', 'transcription factor SOX-10', 3195, 'STAG2APmTOR signalingup9'), ('PR_000006979', 'eukaryotic translation initiation factor 3 subunit G', 3235, 'EIF4B'), ('PR_000010990', 'N-alpha-acetyltransferase 16, NatA auxiliary subunit', 3242, 'NAPEPLD'), ('PR_000012722', 'phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform', 3251, 'PIK3R1'), ('PR_000013090', 'protein phosphatase 1A', 3259, 'PPP2CA'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 3267, 'PPP2CB'), ('PR_000013133', 'neurabin-2', 3275, 'PPP2R2A'), ('PR_000013133', 'neurabin-2', 3284, 'PPP2R5A'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 3293, 'PPP2R5E'), ('PR_000013282', 'pre-mRNA-processing factor 39', 3302, 'PRKAA1'), ('PR_000013282', 'pre-mRNA-processing factor 39', 3310, 'PRKAA2'), ('PR_000013222', 'cAMP-dependent protein kinase catalytic subunit alpha', 3318, 'PRKAB2'), ('GO_0008306', 'associative learning', 3356, 'cycle regulationup6'), ('PR_000008300', 'glutathione S-transferase mu 1', 3389, 'GSK3B'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 3396, 'HDAC2'), ('PR_000013090', 'protein phosphatase 1A', 3403, 'PPP2CA'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 3411, 'PPP2CB'), ('PR_000013133', 'neurabin-2', 3419, 'PPP2R2A'), ('PR_000013133', 'neurabin-2', 3428, 'PPP2R5A'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 3437, 'PPP2R5E'), ('PR_000013739', 'retinoic acid receptor responder protein 1', 3446, 'RAF1'), ('GO_0008150', 'biological_process', 3466, 'metabolismup8'), ('PR_000010977', 'nucleosome assembly protein 1-like 3', 3485, '320AMPD3'), ('PR_000004405', 'activating transcription factor 7-interacting protein 1', 3495, 'ATF7IP'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 3503, 'ATP6V0E1'), ('PR_000004489', 'V-type proton ATPase subunit G 1', 3513, 'ATP6V1G2'), ('PR_000029393', 'probable ATP-dependent RNA helicase DDX56', 3523, 'DDX19B'), ('PR_000006971', 'eukaryotic translation initiation factor 2 subunit 1', 3531, 'EIF2AK4'), ('PR_000010040', 'mitotic spindle assembly checkpoint protein MAD2B', 3540, 'MAD2L2'), ('PR_000010550', '3-mercaptopyruvate sulfurtransferase', 3548, 'MPP1'), ('PR_000011286', 'nucleoside diphosphate kinase 6', 3554, 'NME6'), ('PR_000011459', 'neurotrophin-3', 3560, 'NT5C3'), ('PR_000012978', 'DNA polymerase lambda', 3567, 'POLG'), ('PR_000012989', 'DNA-directed RNA polymerase II subunit RPB3', 3573, 'POLR1A'), ('PR_000012980', 'DNA polymerase nu', 3581, 'POLR2C'), ('PR_000012980', 'DNA polymerase nu', 3589, 'POLR2F'), ('PR_000013058', 'peroxisome proliferator-activated receptor gamma', 3597, 'PPAT'), ('PR_000013379', '26S proteasome regulatory subunit 7', 3603, 'PSMC1'), ('PR_000013379', '26S proteasome regulatory subunit 7', 3610, 'PSMC3'), ('PR_000013379', '26S proteasome regulatory subunit 7', 3617, 'PSMC5'), ('PR_000013900', 'DNA polymerase zeta catalytic subunit', 3624, 'RFC3'), ('GO_0008150', 'biological_process', 3646, 'metabolismup2'), ('PR_000007365', 'fructose-1,6-bisphosphatase 1', 3665, '211CMPK1'), ('PR_000006971', 'eukaryotic translation initiation factor 2 subunit 1', 3675, 'EIF2AK4'), ('PR_000010040', 'mitotic spindle assembly checkpoint protein MAD2B', 3684, 'MAD2L2'), ('PR_000011286', 'nucleoside diphosphate kinase 6', 3692, 'NME6'), ('PR_000011459', 'neurotrophin-3', 3698, 'NT5C3'), ('PR_000011528', 'nucleoporin NUP42', 3705, 'NXN'), ('PR_000012978', 'DNA polymerase lambda', 3710, 'POLG'), ('PR_000012989', 'DNA-directed RNA polymerase II subunit RPB3', 3716, 'POLR1A'), ('PR_000012980', 'DNA polymerase nu', 3724, 'POLR2C'), ('PR_000012980', 'DNA polymerase nu', 3732, 'POLR2F'), ('PR_000014378', 'ryanodine receptor 2', 3761, 'receptor signalingup2'), ('PR_000006069', 'C-X-C motif chemokine 2', 3801, 'CXCL3'), ('PR_000007140', 'epsin-3', 3808, 'EP300'), ('PR_000008812', 'heat shock cognate 71 kDa protein', 3815, 'HSP90AA1'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 3825, 'MAP3K14'), ('PR_000011209', 'nidogen-2', 3834, 'NCOA2'), ('PR_000001622', 'neuropeptide Y receptor type 1', 3841, 'NCOR2'), ('PR_000011403', 'photoreceptor-specific nuclear receptor', 3848, 'NR3C1'), ('PR_000012777', 'fibrocystin', 3855, 'PIK3C3'), ('PR_000012980', 'DNA polymerase nu', 3863, 'POLR2C'), ('PR_000012980', 'DNA polymerase nu', 3871, 'POLR2F'), ('PR_000000364', 'smad2', 3879, 'SMAD3'), ('PR_000015790', 'syntaxin-18', 3886, 'STAT5B'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 3954, 'COX6A1'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 3962, 'COX7C'), ('PR_000009089', 'importin-7', 3969, 'IP6K2'), ('PR_000011099', 'NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial', 3976, 'NDUFA2'), ('PR_000011050', 'kinetochore protein NDC80', 3984, 'NDUFB3'), ('PR_000011050', 'kinetochore protein NDC80', 3992, 'NDUFB5'), ('PR_000011099', 'NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial', 4000, 'NDUFB6'), ('PR_000011050', 'kinetochore protein NDC80', 4008, 'NDUFB10'), ('PR_000011050', 'kinetochore protein NDC80', 4017, 'NDUFS3'), ('PR_000011159', 'nexilin', 4025, 'NDUFS4'), ('PR_000011050', 'kinetochore protein NDC80', 4033, 'NDUFS6'), ('PR_000013060', 'peroxisome proliferator-activated receptor gamma coactivator 1-beta', 4041, 'PPA2'), ('PR_000013431', 'tuberoinfundibular peptide of 39 residues', 4071, 'Polo-like kinasedown2'), ('PR_000010300', 'mediator of RNA polymerase II transcription subunit 28', 4098, '26CCNB2'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 4107, 'CDK1'), ('PR_000012888', 'phospholipid transfer protein', 4113, 'PLK4'), ('PR_000013270', 'pyridoxal phosphate homeostasis protein PLPBP', 4119, 'PRC1'), ('PR_000013459', 'tyrosine-protein phosphatase non-receptor type 4', 4125, 'PTTG1'), ('PR_000017400', 'WD repeat-containing protein 82', 4132, 'WEE1HPG2'), ('GO_0000729', 'DNA double-strand break processing', 4143, 'DNA damage checkpoint regulationdown2'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 4186, '25CCNB2'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 4195, 'CDK1'), ('PR_000005593', 'ceroid-lipofuscinosis neuronal protein 6', 4201, 'CKS1B'), ('PR_000017405', 'WAP four-disulfide core domain protein 1', 4208, 'WEE1')]
S84-PMC3342123	PMC3342123	3/2012	S84-PMC3342123	['of Regulated Genesgenes involved in pathway94 dpc vs. 1 dpn ap Ampk Signalingup6.96*e-38Akt2, Insr, Pik3C2A, Pik3R1, Ppm1B, Prkaa1, Prkacb, Rac1 ap mitotic roles of Polo- Like Kinasedown3.25*e-47Ccnb1, Ccnb2, Cdc25B, Chek2, Kif11, Plk4, pttg1 ap Pyrimidine Metabolismdown2.52*e-310cad, dctd, Dkc1, Polq, Polr3E, Polr3K, Rfc5, Rrm1, Tyms, Uck2 ap g2/m Dna Damage Checkpoint Regulationdown2.04*e-46Ccnb1, Ccnb2, Cdc25B, Chek2, ubc, ywhae lp purine Metabolismup9.20*e-312ddx39, Pnpt1, Pola2, Pole2, Polr1B, Polr1C, Polr2I, Rfc3, Rrm2, Rrm2B, ruvbl1, ruvbl2 lp Pyrimidine Metabolismup6.15*e-714ctps, Pnpt1, Pola2, Pole2, Polr1B, Polr1C, Polr2I, pus1, Rfc3, Rrm2, Rrm2B, Txnrd1, Tyms, Uck2 lp mitotic roles of Polo- Like Kinaseup7.55*e-57anapc4, Cdc27, Cdk1, Espl1, Fzr1, Ppp2R1B, Pttg1 lp G2/M Dna Damage Checkpoint Regulationup3.09*e-23Cdk1, Chek1, ywhaz lp Wnt Signalingdown4.02*e-29Akt3, Fzd5, Mmp7, Nlk, Sox4, tcf3, Tcf4, Tcf7L2, Wnt5A1 dpn vs. 28 dpn ap ampk signalingup4.26*e-38Ak1, Cpt1A, Eif4Ebp1, Hmgcr, Mapk14, Nos3, Prkaa2, Prkab2 ap Mtor Signalingup1.89*e-27eif3f, Eif3G, Eif4Ebp1, Fnbp1, Gnb1L, Prkaa2, Prkab2 ap val, leu, ile degradationdown6.40*e-36acad8, acadl, acadsb, Bcat1, dbt, Mccc2 lp val, leu, ile degradationup7.12*e-811acadsb, Acat1, Acat2, Aldh1A1, auh, bckdhb, gcdh, Hmgcl, Hmgcs1, Mccc2, Mcee lp Fatty Acid metabolismup3.23*e-38acadsb, Acat1, Acat2, Aldh1A1, auh, Cyp51A1, gcdh, Peci lp Synthesis and Degradation Of Ketone Bodiesup1.76*e-65acat1, acat2, bdh2, hmgcl, Hmgcs1 lp Biosynthesis Of Steroidsup3.27*e-45cyp24a1, fdps, hmgcr, Idi1, sc5dl lp glucocorticoid Receptor Signalingup3.57*e-312cdkn1c, Cxcl3, Il10, Map3K1, Ncoa2, Nfkbib, Nr3C1, Polr2B, Prkacb, Rras2, Slpi, Smarca4 lp g1/s Checkpoint Regulationdown2.22*e-24ccne1, Cdc25A, Cdkn1A, e2f328 dpn vs. 188 dpn ap Ampk Signalingup1.50*e-310insr, Mapk12, ppat, Ppm1A, Ppp2Ca, Ppp2R3A, Prkaa2, Smarca2, Src, Stk11 ap Fatty Acid Metabolismup1.28*e-28acadsb, Aldh1A1, Cyp1B1, Cyp2D6, Cyp3A4, Cyp4A11, Cyp4B1, Peci ap mitotic roles of Polo- Like Kinasedown8.33*e-37anapc5, Cdk1, Plk1, Plk2, Ppp2R1B, Slk, Wee1 ap Vegf Signalingdown7.3*e-39Akt3, Bcl2, Kdr, Nos3, Prkcb, Rac2, Rras, Vcl, vegfc lp val, leu, ile Degradationup1.07*e-27acaa1, Acat1, Aldh1B1, auh, ech1, ivd, Iws1 lp Fatty Acid elongation in Mitochondriaup2.05*e-23acaa1, auh, ech1 lp Mtor Signalingup2.65*e-210Akt3, Ddit4, Eif4B, Eif4G3, Ppp2R1B, Prkab2, Prkag1, Prkag2, Tsc1, vegfa lp Actin Cytoskeleton signalingdown7.99*e-524actb, Actr2, Arpc4, Arpc1A, cd14, Cfl1, F2R, Fgd1, Lbp, Map2K1,Myh9, Nckap1, Pak2, Pik3C3, Pik3C2A, Pik3R4, Pikfyve, Ppp1R12A, Rdx, Rock1, Rock2, tmsb4x, Tmsl3, Wasf1 lp Rhoa signalingdow5.05*e-3n12actb, Actr2, Arhgap1, Arpc4, Arpc1A, Cfl1, Pikfyve, Ppp1R12A, rdx, Rock1, Rock2, Wasf1 lp Rac signalingdown4.34*e-312Actr2, Arpc4, Arpc1A, Cfl1, Map2K1, Nckap1, Pak2, Pik3C3, Pik3C2A, Pik3R4, Pikfyve, Wasf1 lp complement systemdown2.17*e-25c2, c7, c9, cfb, Mbl2\nthe comparison between the dietary Gestational protein diets (lp vs. ap) is shown in dependence of the Regulatory direction (up or down).']	N/A	N/A	[('GO_0065007', 'biological regulation', 3, 'regulated'), ('SO_0000704', 'gene', 13, 'genesGenes'), ('GO_0036165', 'invasive growth in response to heat', 63, 'AMPK signalingup6'), ('PR_000008770', 'corticosteroid 11-beta-dehydrogenase isozyme 1', 86, '38AKT2'), ('PR_000008989', 'interleukin-1 family member 7', 94, 'INSR'), ('PR_000012747', '1-phosphatidylinositol 3-phosphate 5-kinase', 100, 'PIK3C2A'), ('PR_000012722', 'phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform', 109, 'PIK3R1'), ('PR_000013059', 'peroxisome proliferator-activated receptor gamma coactivator 1-alpha', 117, 'PPM1B'), ('PR_000013282', 'pre-mRNA-processing factor 39', 124, 'PRKAA1'), ('PR_000013502', 'parvalbumin alpha', 132, 'PRKACB'), ('PR_000013739', 'retinoic acid receptor responder protein 1', 140, 'RAC1'), ('PR_000013439', 'prostate tumor-overexpressed gene 1 protein', 165, 'Polo- like kinasedown3'), ('PR_000012509', 'PDZ and LIM domain protein 2', 193, '47CCNB1'), ('PR_000005155', 'T-complex protein 1 subunit zeta-2', 202, 'CCNB2'), ('PR_000005205', 'serine/threonine-protein kinase MRCK alpha', 209, 'CDC25B'), ('PR_000005399', 'glutathione-specific gamma-glutamylcyclotransferase 2', 217, 'CHEK2'), ('PR_000009291', 'kinesin-like protein KIF17', 224, 'KIF11'), ('PR_000012888', 'phospholipid transfer protein', 231, 'PLK4'), ('CHEBI_30954', 'pyridazine', 246, 'Pyrimidine'), ('GO_0016441', 'posttranscriptional gene silencing', 246, 'Pyrimidine metabolismdown2'), ('PR_000006450', 'diacylglycerol kinase theta', 292, 'DKC1'), ('PR_000012968', 'polymerase delta-interacting protein 3', 298, 'POLQ'), ('PR_000012980', 'DNA polymerase nu', 304, 'POLR3E'), ('PR_000012980', 'DNA polymerase nu', 312, 'POLR3K'), ('PR_000013939', 'Ral-GDS-related protein', 320, 'RFC5'), ('PR_000014318', 'radical S-adenosyl methionine domain-containing protein 2', 326, 'RRM1'), ('PR_000016850', 'tyrosine-protein kinase TXK', 332, 'TYMS'), ('PR_000017029', 'uridine-cytidine kinase 2', 338, 'UCK2'), ('GO_0000729', 'DNA double-strand break processing', 351, 'DNA damage checkpoint regulationdown2'), ('PR_000012490', 'platelet-derived growth factor subunit A', 394, '46CCNB1'), ('PR_000005155', 'T-complex protein 1 subunit zeta-2', 403, 'CCNB2'), ('PR_000005205', 'serine/threonine-protein kinase MRCK alpha', 410, 'CDC25B'), ('PR_000005399', 'glutathione-specific gamma-glutamylcyclotransferase 2', 418, 'CHEK2'), ('GO_0015948', 'methanogenesis', 446, 'metabolismup9'), ('PR_000013050', 'suppressor of SWI4 1', 475, 'PNPT1'), ('PR_000012930', 'paraneoplastic antigen Ma2', 482, 'POLA2'), ('PR_000012933', 'paraneoplastic antigen-like protein 6A', 489, 'POLE2'), ('PR_000012980', 'DNA polymerase nu', 496, 'POLR1B'), ('PR_000012989', 'DNA-directed RNA polymerase II subunit RPB3', 504, 'POLR1C'), ('PR_000012970', 'DNA polymerase epsilon subunit 2', 512, 'POLR2I'), ('PR_000013900', 'DNA polymerase zeta catalytic subunit', 520, 'RFC3'), ('PR_000014318', 'radical S-adenosyl methionine domain-containing protein 2', 526, 'RRM2'), ('PR_000014318', 'radical S-adenosyl methionine domain-containing protein 2', 532, 'RRM2B'), ('CHEBI_30954', 'pyridazine', 557, 'Pyrimidine'), ('GO_0019233', 'sensory perception of pain', 557, 'Pyrimidine'), ('GO_0008150', 'biological_process', 568, 'metabolismup6'), ('PR_000013050', 'suppressor of SWI4 1', 596, 'PNPT1'), ('PR_000012930', 'paraneoplastic antigen Ma2', 603, 'POLA2'), ('PR_000012933', 'paraneoplastic antigen-like protein 6A', 610, 'POLE2'), ('PR_000012980', 'DNA polymerase nu', 617, 'POLR1B'), ('PR_000012989', 'DNA-directed RNA polymerase II subunit RPB3', 625, 'POLR1C'), ('PR_000012970', 'DNA polymerase epsilon subunit 2', 633, 'POLR2I'), ('PR_000013900', 'DNA polymerase zeta catalytic subunit', 647, 'RFC3'), ('PR_000014318', 'radical S-adenosyl methionine domain-containing protein 2', 653, 'RRM2'), ('PR_000014318', 'radical S-adenosyl methionine domain-containing protein 2', 659, 'RRM2B'), ('PR_000016869', 'thioredoxin-like protein 4A', 666, 'TXNRD1'), ('PR_000016850', 'tyrosine-protein kinase TXK', 674, 'TYMS'), ('PR_000017029', 'uridine-cytidine kinase 2', 680, 'UCK2'), ('PR_000012720', 'phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform', 705, 'Polo- like kinaseup7'), ('PR_000005195', 'cell division cycle protein 27', 741, 'CDC27'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 748, 'CDK1'), ('PR_000007164', 'general transcription and DNA repair factor IIH helicase subunit XPD', 754, 'ESPL1'), ('PR_000001445', 'discoidin domain-containing receptor 1', 761, 'FZR1'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 767, 'PPP2R1B'), ('PR_000013459', 'tyrosine-protein phosphatase non-receptor type 4', 776, 'PTTG1'), ('GO_0044839', 'cell cycle G2/M phase transition', 785, 'G2/M'), ('GO_0000077', 'DNA damage checkpoint signaling', 790, 'DNA damage checkpoint'), ('PR_000013900', 'DNA polymerase zeta catalytic subunit', 812, 'regulationup3'), ('PR_000007355', 'Fas-binding factor 1', 831, '23CDK1'), ('PR_000005399', 'glutathione-specific gamma-glutamylcyclotransferase 2', 839, 'CHEK1'), ('GO_0090475', 'lys-lys specific dibasic protein processing', 855, 'Wnt signalingdown4'), ('PR_000015050', 'long-chain fatty acid transport protein 6', 879, '29AKT3'), ('PR_000007719', 'frizzled-2', 887, 'FZD5'), ('PR_000010482', 'matrix metalloproteinase-23', 893, 'MMP7'), ('PR_000011279', 'neuromedin-B', 899, 'NLK'), ('PR_000015432', 'transcription factor SOX-6', 904, 'SOX4'), ('PR_000016190', 'trichohyalin-like protein 1', 916, 'TCF4'), ('PR_000016139', 'TATA box-binding protein-like 2', 922, 'TCF7L2'), ('PR_000017438', 'protein Wnt-11', 930, 'WNT5A1'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 978, '38AK1'), ('PR_000005800', 'carboxypeptidase A6', 985, 'CPT1A'), ('PR_000006970', 'protein argonaute-4', 992, 'EIF4EBP1'), ('PR_000008629', 'high mobility group protein HMGI-C', 1002, 'HMGCR'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 1009, 'MAPK14'), ('PR_000011333', 'notch homolog 2 N-terminal-like protein A', 1017, 'NOS3'), ('PR_000013282', 'pre-mRNA-processing factor 39', 1023, 'PRKAA2'), ('PR_000013222', 'cAMP-dependent protein kinase catalytic subunit alpha', 1031, 'PRKAB2'), ('PR_000029774', 'probable cysteine--tRNA ligase, mitochondrial', 1041, 'mTOR signalingup1'), ('PR_000006979', 'eukaryotic translation initiation factor 3 subunit G', 1073, 'EIF3G'), ('PR_000006970', 'protein argonaute-4', 1080, 'EIF4EBP1'), ('PR_000007583', 'ketosamine-3-kinase', 1090, 'FNBP1'), ('PR_000008081', 'guanine nucleotide-binding protein subunit alpha-12', 1097, 'GNB1L'), ('PR_000013282', 'pre-mRNA-processing factor 39', 1104, 'PRKAA2'), ('PR_000013222', 'cAMP-dependent protein kinase catalytic subunit alpha', 1112, 'PRKAB2'), ('PR_000004648', 'spliceosome RNA helicase BAT1', 1182, 'BCAT1'), ('PR_000010242', 'DNA replication licensing factor MCM2', 1194, 'MCCC2'), ('PR_000003666', 'acyl-coenzyme A synthetase ACSM2B, mitochondrial', 1248, 'ACAT1'), ('PR_000003666', 'acyl-coenzyme A synthetase ACSM2B, mitochondrial', 1255, 'ACAT2'), ('PR_000003923', 'aldehyde dehydrogenase X, mitochondrial', 1262, 'ALDH1A1'), ('PR_000008651', 'jupiter microtubule associated homolog 2', 1290, 'HMGCL'), ('PR_000008653', 'hepatocyte nuclear factor 1-beta', 1297, 'HMGCS1'), ('PR_000010242', 'DNA replication licensing factor MCM2', 1305, 'MCCC2'), ('PR_000010230', 'membrane-bound transcription factor site-2 protease', 1312, 'MCEE'), ('CHEBI_35366', 'fatty acid', 1320, 'Fatty acid'), ('PR_000003666', 'acyl-coenzyme A synthetase ACSM2B, mitochondrial', 1360, 'ACAT1'), ('PR_000003666', 'acyl-coenzyme A synthetase ACSM2B, mitochondrial', 1367, 'ACAT2'), ('PR_000003923', 'aldehyde dehydrogenase X, mitochondrial', 1374, 'ALDH1A1'), ('PR_000006101', 'cytochrome P450 1A1', 1388, 'CYP51A1'), ('PR_000012524', 'pyridoxal kinase', 1403, 'PECI'), ('GO_0007416', 'synapse assembly', 1411, 'Synthesis ...'), ('GO_0009600', 'detection of nematode', 1425, 'degradation of ketone'), ('CHEBI_17087', 'ketone', 1440, 'ketone'), ('PR_000002318', 'caspase-9', 1447, 'bodiesup1'), ('PR_000008653', 'hepatocyte nuclear factor 1-beta', 1491, 'HMGCS1'), ('GO_0033576', 'protein glycosylation in cytosol', 1501, 'Biosynthesis of steroidsup3'), ('CHEBI_32158', 'streptomycin sulfate', 1517, 'steroidsup3'), ('PR_000008893', 'isopentenyl-diphosphate Delta-isomerase 2', 1558, 'IDI1'), ('PR_000014378', 'ryanodine receptor 2', 1588, 'receptor signalingup3'), ('PR_000006069', 'C-X-C motif chemokine 2', 1626, 'CXCL3'), ('PR_000001470', 'interleukin-28B', 1633, 'IL10'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 1639, 'MAP3K1'), ('PR_000011209', 'nidogen-2', 1647, 'NCOA2'), ('PR_000011117', 'enhancer of filamentation 1', 1654, 'NFKBIB'), ('PR_000011403', 'photoreceptor-specific nuclear receptor', 1662, 'NR3C1'), ('PR_000012980', 'DNA polymerase nu', 1669, 'POLR2B'), ('PR_000013502', 'parvalbumin alpha', 1677, 'PRKACB'), ('PR_000014318', 'radical S-adenosyl methionine domain-containing protein 2', 1685, 'RRAS2'), ('PR_000015619', 'sorcin', 1692, 'SLPI'), ('PR_000015266', 'SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2', 1698, 'SMARCA4'), ('GO_0000724', 'double-strand break repair via homologous recombination', 1714, 'checkpoint regulationdown2'), ('PR_000005155', 'T-complex protein 1 subunit zeta-2', 1755, 'CDC25A'), ('PR_000005259', 'cyclin-dependent kinase 5 activator 1', 1763, 'CDKN1A'), ('GO_0034356', 'NAD biosynthesis via nicotinamide riboside salvage pathway', 1797, 'AMPK signalingup1'), ('PR_000014760', 'serine/arginine-rich splicing factor 3', 1802, 'signalingup1'), ('PR_000010157', 'mitogen-activated protein kinase 4', 1829, 'MAPK12'), ('PR_000013090', 'protein phosphatase 1A', 1843, 'PPM1A'), ('PR_000013090', 'protein phosphatase 1A', 1850, 'PPP2CA'), ('PR_000013133', 'neurabin-2', 1858, 'PPP2R3A'), ('PR_000013282', 'pre-mRNA-processing factor 39', 1867, 'PRKAA2'), ('PR_000000364', 'smad2', 1875, 'SMARCA2'), ('PR_000015643', 'sex-determining region Y protein', 1884, 'SRC'), ('PR_000015770', 'storkhead-box protein 2', 1889, 'STK11'), ('CHEBI_35366', 'fatty acid', 1898, 'Fatty acid'), ('GO_0036337', 'Fas signaling pathway', 1898, 'Fatty acid metabolismup1'), ('PR_000003923', 'aldehyde dehydrogenase X, mitochondrial', 1938, 'ALDH1A1'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 1947, 'CYP1B1'), ('PR_000006099', 'cytochrome P450 17A1', 1955, 'CYP2D6'), ('PR_000006131', 'cytochrome P450 3A43', 1963, 'CYP3A4'), ('PR_000006101', 'cytochrome P450 1A1', 1971, 'CYP4A11'), ('PR_000006101', 'cytochrome P450 1A1', 1980, 'CYP4B1'), ('PR_000012524', 'pyridoxal kinase', 1988, 'PECI'), ('PR_000014700', 'serpin B9', 2013, 'Polo- like kinasedown8'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 2051, 'CDK1'), ('PR_000012888', 'phospholipid transfer protein', 2057, 'PLK1'), ('PR_000012838', '1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1', 2063, 'PLK2'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 2069, 'PPP2R1B'), ('PR_000000123', 'ribosomal protein S6 kinase beta-1', 2078, 'SLK'), ('PR_000017405', 'WAP four-disulfide core domain protein 1', 2083, 'WEE1'), ('GO_0038084', 'vascular endothelial growth factor signaling pathway', 2091, 'VEGF signalingdown7'), ('PR_000005050', 'kinetochore scaffold 1', 2115, '39AKT3'), ('PR_000004698', 'Bcl-2-like protein 2', 2123, 'BCL2'), ('PR_000009225', 'junctophilin-4', 2129, 'KDR'), ('PR_000011333', 'notch homolog 2 N-terminal-like protein A', 2134, 'NOS3'), ('PR_000013502', 'parvalbumin alpha', 2140, 'PRKCB'), ('PR_000013639', 'Ras-related protein Rab-7a', 2147, 'RAC2'), ('PR_000014290', '40S ribosomal protein S7', 2153, 'RRAS'), ('PR_000017279', 'testis-specific basic protein Y 1', 2159, 'VCL'), ('PR_000006299', 'lariat debranching enzyme', 2187, 'degradationup1'), ('PR_000003666', 'acyl-coenzyme A synthetase ACSM2B, mitochondrial', 2216, 'ACAT1'), ('PR_000003923', 'aldehyde dehydrogenase X, mitochondrial', 2223, 'ALDH1B1'), ('PR_000029559', 'interleukin-36 beta', 2248, 'IWS1'), ('CHEBI_35366', 'fatty acid', 2256, 'Fatty acid'), ('GO_0015913', 'short-chain fatty acid import', 2256, 'Fatty acid'), ('GO_0005759', 'mitochondrial matrix', 2281, 'mitochondriaup2'), ('PR_000029775', 'histidine--tRNA ligase, mitochondrial', 2324, 'mTOR signalingup2'), ('PR_000010940', 'NEDD4-binding protein 2-like 2', 2347, '210AKT3'), ('PR_000006330', 'DCN1-like protein 1', 2356, 'DDIT4'), ('PR_000006979', 'eukaryotic translation initiation factor 3 subunit G', 2363, 'EIF4B'), ('PR_000006979', 'eukaryotic translation initiation factor 3 subunit G', 2370, 'EIF4G3'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 2378, 'PPP2R1B'), ('PR_000013222', 'cAMP-dependent protein kinase catalytic subunit alpha', 2387, 'PRKAB2'), ('PR_000013222', 'cAMP-dependent protein kinase catalytic subunit alpha', 2395, 'PRKAG1'), ('PR_000013222', 'cAMP-dependent protein kinase catalytic subunit alpha', 2403, 'PRKAG2'), ('PR_000016770', 'testis-specific serine/threonine-protein kinase 1', 2411, 'TSC1'), ('GO_0015629', 'actin cytoskeleton', 2426, 'Actin cytoskeleton'), ('PR_000003666', 'acyl-coenzyme A synthetase ACSM2B, mitochondrial', 2474, 'ACTR2'), ('PR_000004320', 'beta-arrestin-2', 2481, 'ARPC4'), ('PR_000004207', 'ADP-ribosylation factor GTPase-activating protein 2', 2488, 'ARPC1A'), ('PR_000005398', 'glutathione-specific gamma-glutamylcyclotransferase 1', 2502, 'CFL1'), ('PR_000001445', 'discoidin domain-containing receptor 1', 2508, 'F2R'), ('PR_000007500', 'fibroblast growth factor 9', 2513, 'FGD1'), ('PR_000009677', 'ceramide synthase 1', 2519, 'LBP'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 2524, 'MAP2K1'), ('PR_000010826', 'myosin-2', 2531, 'MYH9'), ('PR_000011158', 'neurogenin-3', 2537, 'NCKAP1'), ('PR_000012272', 'protein PAPPAS', 2545, 'PAK2'), ('PR_000012777', 'fibrocystin', 2551, 'PIK3C3'), ('PR_000012747', '1-phosphatidylinositol 3-phosphate 5-kinase', 2559, 'PIK3C2A'), ('PR_000012727', 'phosphoinositide 3-kinase regulatory subunit 4', 2568, 'PIK3R4'), ('PR_000012777', 'fibrocystin', 2576, 'PIKFYVE'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 2585, 'PPP1R12A'), ('PR_000013890', 'arginine-glutamic acid dipeptide repeats protein', 2595, 'RDX'), ('PR_000014339', 'radial spoke head 14 homolog', 2600, 'ROCK1'), ('PR_000014339', 'radial spoke head 14 homolog', 2607, 'ROCK2'), ('PR_000016443', 'trimethyllysine dioxygenase, mitochondrial', 2622, 'TMSL3'), ('PR_000017376', 'WW domain-binding protein 11', 2629, 'WASF1'), ('PR_000014293', '40S ribosomal protein SA', 2638, 'RhoA'), ('PR_000003666', 'acyl-coenzyme A synthetase ACSM2B, mitochondrial', 2672, 'ACTR2'), ('PR_000004291', 'ADP-ribosylation factor-like protein 6-interacting protein 1', 2679, 'ARHGAP1'), ('PR_000004320', 'beta-arrestin-2', 2688, 'ARPC4'), ('PR_000004207', 'ADP-ribosylation factor GTPase-activating protein 2', 2695, 'ARPC1A'), ('PR_000005398', 'glutathione-specific gamma-glutamylcyclotransferase 1', 2703, 'CFL1'), ('PR_000012777', 'fibrocystin', 2709, 'PIKFYVE'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 2718, 'PPP1R12A'), ('PR_000014339', 'radial spoke head 14 homolog', 2733, 'ROCK1'), ('PR_000014339', 'radial spoke head 14 homolog', 2740, 'ROCK2'), ('PR_000017376', 'WW domain-binding protein 11', 2747, 'WASF1'), ('PR_000013639', 'Ras-related protein Rab-7a', 2756, 'Rac'), ('PR_000005450', 'chromatin accessibility complex protein 1', 2780, '312ACTR2'), ('PR_000004320', 'beta-arrestin-2', 2790, 'ARPC4'), ('PR_000004207', 'ADP-ribosylation factor GTPase-activating protein 2', 2797, 'ARPC1A'), ('PR_000005398', 'glutathione-specific gamma-glutamylcyclotransferase 1', 2805, 'CFL1'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 2811, 'MAP2K1'), ('PR_000011158', 'neurogenin-3', 2819, 'NCKAP1'), ('PR_000012272', 'protein PAPPAS', 2827, 'PAK2'), ('PR_000012777', 'fibrocystin', 2833, 'PIK3C3'), ('PR_000012747', '1-phosphatidylinositol 3-phosphate 5-kinase', 2841, 'PIK3C2A'), ('PR_000012727', 'phosphoinositide 3-kinase regulatory subunit 4', 2850, 'PIK3R4'), ('PR_000012777', 'fibrocystin', 2858, 'PIKFYVE'), ('PR_000017376', 'WW domain-binding protein 11', 2867, 'WASF1'), ('PR_000010220', 'mannose-binding protein C', 2923, 'MBL2'), ('GO_0007565', 'female pregnancy', 2963, 'gestational'), ('GO_0065007', 'biological regulation', 3031, 'regulatory')]
S44-PMC4685088	PMC4685088	12/2015	S44-PMC4685088	['caption (table-wrap): table 1\n\nselected mediators of inflammation, their role, and corresponding Expression in bpd .mediators of inflammationroleexpression in bpd inflammatory cytokines interleukins: anti-inflammatory\u2003il-10suppresses inflammatory response by inhibiting Nf-Κb↓/↔\u2003Il-4, Il-13Suppresses inflammation by inhibiting pro-inflammatory cytokine production↔interleukins: pro-inflammatory\u2003Il-1, Il-6Acute Phase inflammatory response↑\u2003Il-8 (Cxcl-8)main chemoattractant for Neutrophils↑cc chemokines\u2003Monocyte Chemoattractant Protein (Mcp)-1, 1α, 1β, 2, 3recruit Inflammatory Cells to area of injury↑Macrophage Migration Inhibitory Factor (Mif)upstream regulator of Innate Immune Response↓Tumor Necrosis Factor Alpha (Tnf-Α)enhances Expression of other pro-inflammatory cytokines↑Transforming Growth Factor-Beta 1 (Tgf-Β1)pro-inflammatory↑ Matrix proteins Matrix Metalloproteinase-8Disordered Pulmonary remodeling after inflammation↑Matrix Metalloproteinase-9Pro-inflammatory, interferon-gamma (Ifn-Γ) Signaling↑ growth factors Endothelin-1Pro-inflammatory↑Vascular Endothelial growth factorpro-inflammatory↑/↓Connective Tissue growth factor (Ctgf)pro-inflammatory↑bombesin-like peptide (blp)increases Mast Cells in the Lung↑Breast Regression Protein-39 (Human analog is ykl-40)anti-inflammatory↓Pulmonary Hepatocyte Growth Factor (Hgf)Alveolar septation, Repair↓Keratinocyte Growth Factor (Kgf)Regulates Proliferation Of Alveolar Epithelial Cells↓ miscellaneous Interferon-Inducible Protein 9 (Ip-9\u2009–\u2009also known as Cxcl11)pro-inflammatory, Ifn-Γ Signaling↑Cyclooxygenase-2 (Cox-2)pro-inflammatory, Ifn-Γ Signaling↑Ccaat/Enhancer-Binding Protein (C/Ebp)pro-inflammatory, ifn-Γ Signaling↑endoglinpro-inflammatory↑periostinpro-inflammatory↑Clara Cell secretory proteinmodulates acute Pulmonary inflammation↓Parathyroid Hormone-Related Protein (Pthrp)Alveolar growth↓Angiopoietin-2Pro-inflammatory↑lactoferrinanti-inflammatory↓\n↑\u2009–\u2009increase; ↔\u2009–\u2009no change; ↓\u2009–\u2009decrease .']	N/A	N/A	[('GO_0010467', 'gene expression', 97, 'expression'), ('GO_0071159', 'NF-kappaB complex', 270, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 270, 'NF-κB'), ('PR_000001470', 'interleukin-28B', 279, 'IL-4'), ('PR_000029553', 'interferon-induced protein with tetratricopeptide repeats 5', 285, 'IL-13Suppresses'), ('PR_000001470', 'interleukin-28B', 396, 'IL-1'), ('PR_000001364', 'interleukin-1 receptor type II', 402, 'IL-6Acute'), ('GO_0051324', 'prophase', 412, 'phase'), ('PR_000001470', 'interleukin-28B', 441, 'IL-8'), ('PR_000001208', 'C-X-C chemokine receptor type 4', 447, 'CXCL-8'), ('CL_0000775', 'neutrophil', 479, 'neutrophils'), ('CL_0000576', 'monocyte', 505, 'Monocyte'), ('PR_000010704', 'metallothionein-2', 505, 'Monocyte chemoattractant protein ...'), ('PR_000010220', 'mannose-binding protein C', 539, 'MCP)-1'), ('CL_0000902', 'induced T-regulatory cell', 567, 'inflammatory cells'), ('CL_0000235', 'macrophage', 604, 'Macrophage'), ('GO_0003138', 'primary heart field specification', 604, 'Macrophage migration'), ('PR_000010193', 'mannan-binding lectin serine protease 1', 604, 'Macrophage migration inhibitory factor'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 644, 'MIF'), ('GO_0002244', 'hematopoietic progenitor cell differentiation', 670, 'innate immune response↓'), ('UBERON_0002405', 'immune system', 677, 'immune'), ('PR_000016190', 'trichohyalin-like protein 1', 693, 'Tumor necrosis factor alpha'), ('PR_000000134', 'tumor necrosis factor alpha', 722, 'TNF-α'), ('GO_0010467', 'gene expression', 737, 'expression'), ('PR_000001933', 'signal transducer and transcription activator STAT', 784, 'Transforming growth factor'), ('PR_000004691', 'B-cell lymphoma/leukemia 11B', 811, 'beta 1'), ('PR_000000183', 'TGF-beta 2', 819, 'TGF-β1'), ('GO_0031430', 'M band', 844, 'Matrix'), ('GO_0031430', 'M band', 860, 'Matrix'), ('PR_000015455', 'sperm-associated antigen 16 protein', 860, 'Matrix metalloproteinase-8Disordered'), ('UBERON_0002048', 'lung', 897, 'pulmonary'), ('GO_0031430', 'M band', 937, 'Matrix'), ('PR_000010755', 'metaxin-1', 937, 'Matrix metalloproteinase-9Pro'), ('GO_0038171', 'cannabinoid signaling pathway', 999, 'IFN- ... signaling'), ('PR_000008920', 'interferon alpha-7', 999, 'IFN-γ'), ('PR_000007020', 'ETS-related transcription factor Elf-1', 1032, 'Endothelin-1Pro'), ('UBERON_0006849', 'scapula', 1061, 'Vascular'), ('UBERON_0001986', 'endothelium', 1070, 'endothelial'), ('UBERON_0003588', 'forelimb connective tissue', 1114, 'Connective tissue'), ('PR_000006022', 'lysosomal protective protein', 1147, 'CTGF'), ('CL_0000097', 'mast cell', 1206, 'mast cells'), ('UBERON_0002048', 'lung', 1224, 'lung'), ('PR_000004803', 'breast cancer type 1 susceptibility protein', 1229, 'Breast regression protein-39'), ('UBERON_0000310', 'breast', 1229, 'Breast'), ('GO_0060033', 'anatomical structure regression', 1236, 'regression'), ('NCBITaxon_9606', 'Homo sapiens', 1259, 'human'), ('CL_0002241', 'pulmonary interstitial fibroblast', 1300, 'Pulmonary hepatocyte'), ('PR_000001908', 'platelet glycoprotein Ib beta chain', 1300, 'Pulmonary hepatocyte growth factor'), ('UBERON_0002048', 'lung', 1300, 'Pulmonary'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 1336, 'HGF'), ('UBERON_0003215', 'alveolus', 1340, 'Alveolar'), ('GO_0006281', 'DNA repair', 1360, 'repair'), ('GO_0007567', 'parturition', 1366, '↓'), ('CL_0000312', 'keratinocyte', 1367, 'Keratinocyte'), ('PR_000009266', 'calcium-activated potassium channel subunit beta-1', 1367, 'Keratinocyte growth factor'), ('PR_000009311', 'kinesin-like protein KIF3A', 1395, 'KGF'), ('GO_0065007', 'biological regulation', 1399, 'Regulates'), ('GO_0006626', 'protein targeting to mitochondrion', 1409, 'proliferation of ... epithelial cells↓'), ('CL_0000322', 'pneumocyte', 1426, 'alveolar epithelial cells↓'), ('UBERON_0004821', 'pulmonary alveolus epithelium', 1426, 'alveolar epithelial'), ('PR_000029559', 'interleukin-36 beta', 1467, 'Interferon-inducible protein 9'), ('PR_000008989', 'interleukin-1 family member 7', 1499, 'IP-9'), ('PR_000006079', 'cytochrome b5 type B', 1520, 'CXCL11'), ('GO_0038043', 'interleukin-5-mediated signaling pathway', 1545, 'IFN-γ signaling'), ('PR_000008920', 'interferon alpha-7', 1545, 'IFN-γ'), ('PR_000005806', 'cytoplasmic polyadenylation element-binding protein 2', 1561, 'Cyclooxygenase-2'), ('PR_000003266', 'collagen type II alpha chain', 1579, 'Cox-2'), ('GO_0038043', 'interleukin-5-mediated signaling pathway', 1603, 'IFN-γ signaling'), ('PR_000008920', 'interferon alpha-7', 1603, 'IFN-'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 1619, 'CCAAT/enhancer-binding protein'), ('SO_0000165', 'enhancer', 1625, 'enhancer'), ('PR_000005309', 'CCAAT/enhancer-binding protein delta', 1651, 'C/EBP'), ('GO_0007229', 'integrin-mediated signaling pathway', 1679, 'γ signaling'), ('CL_0000574', 'erythrophore', 1742, 'Clara cell'), ('UBERON_0002048', 'lung', 1786, 'pulmonary'), ('PR_000013535', 'putative 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase', 1809, 'Parathyroid hormone-related protein'), ('UBERON_0001132', 'parathyroid gland', 1809, 'Parathyroid'), ('PR_000013439', 'prostate tumor-overexpressed gene 1 protein', 1846, 'PTHrP'), ('UBERON_0003215', 'alveolus', 1852, 'Alveolar'), ('PR_000004009', 'alpha-amylase 2B', 1868, 'Angiopoietin-2Pro')]
S105-PMC4208652	PMC4208652	6/2014	S105-PMC4208652	['(2008)* ●Cdk6 Cyclin‐Dependent Kinase 6 Centa2 Centaurin Alpha 2 Chchd7 coiled‐Coil‐Helix‐Coiled‐Coil‐Helix Domain Containing 7 coil Coilin Cpsf2 Cleavage And Polyadenylation Specific Factor 2 ●Crlf3 Cytokine Receptor Like Factor 3 Dcc deleted in Colon carcinomapark et al.']	N/A	N/A	[('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 9, 'CDK6'), ('PR_000004914', 'carbonic anhydrase-related protein 11', 14, 'Cyclin‐dependent kinase 6'), ('PR_000005393', 'cingulin', 40, 'CENTA2'), ('PR_000000689', 'cation channel sperm-associated protein 2 isoform 1', 47, 'Centaurin alpha 2'), ('PR_000029353', 'centrosomal protein of 89 kDa', 65, 'CHCHD7'), ('SO_0001080', 'coiled_coil', 79, 'coil'), ('SO_0001114', 'peptide_helix', 84, 'helix'), ('SO_0001156', 'DRE_motif', 90, 'coiled‐coil‐helix'), ('PR_000006355', 'ATP-dependent RNA helicase DDX1', 108, 'domain containing 7'), ('SO_0000417', 'polypeptide_domain', 108, 'domain'), ('PR_000006002', 'CTD small phosphatase-like protein 2', 133, 'Coilin'), ('PR_000005800', 'carboxypeptidase A6', 140, 'CPSF2'), ('PR_000005366', 'cocaine esterase', 146, 'Cleavage and polyadenylation specific factor 2'), ('GO_0043631', 'RNA polyadenylation', 159, 'polyadenylation'), ('PR_000005878', 'cysteine-rich secretory protein 1', 194, 'CRLF3'), ('PR_000005179', 'CD99 molecule-like protein 2', 200, 'Cytokine receptor like factor 3'), ('PR_000006317', 'mRNA-decapping enzyme 1A', 232, 'DCC'), ('UBERON_0001155', 'colon', 247, 'colon')]
S27-PMC3423345	PMC3423345	8/2012	S27-PMC3423345	['10-formyl-thf: 10-Formyl-Tetrahydrofolate; 5,10-Ch\u200a=\u200athf: 5,10-methenyltetrahydrofolate; 5,10-Ch2-thf: 5,10-Methylenetetrahydrofolate; 5-Ch3-thf: 5-Methyltetrahydrofolate; badh: betaine Aldehyde dehydrogenase; bhmt: betaine-Homocysteine s -methyltransferase; Cbs: cystathionine beta synthase; chdh: Choline dehydrogenase; cys: cysteine; cshmt: Cytoplasmic serine hydroxymethyltransferase; dd: Dimethylglycine dehydrogenase; Dhf: Dihydrofolate; dhfr: Dihydrofolatereductase; dmg: dimethylglycine; dump: 2′-Deoxyuridine 5′-monophosphate; ftd: 10-Formyl-Tetrahydrofolate dehydrogenase; fts: 10-Formyl-Tetrahydrofolate synthase; gdc: glycine decarboxylase; gly: glycine; Gnmt: glycine n -methyltransferase; Hcy: Homocysteine; mat, methionine adenosyltransferase; met: methionine; ms: methionine synthase; mshmt: Mitochondrial serine hydroxymethyltransferase; mtch: 5,10-Methylenetetrahydrofolate Cyclohydrolase; mthfd: 5,10-Methylenetetrahydrofolate dehydrogenase; mthfr: 5,10-Methylenetetrahydrofolate reductase; mts, s -adenosyl methionine-dependent methyltransferases; sah, s -Adenosyl Homocysteine; sahh: S -Adenosyl Homocysteine hydrolase; sam: S -Adenosyl Methionine; Sarc: Sarcosine; Sdh: sarcosine dehydrogenase; ser: serine; thf: Tetrahydrofolate; ts: thymidylate synthase.']	N/A	N/A	[('CHEBI_42485', 'formyl group', 18, 'formyl'), ('CHEBI_67016', 'tetrahydrofolate', 25, 'tetrahydrofolate'), ('CHEBI_17996', 'chloride', 48, 'CH'), ('CHEBI_17883', 'hydrogen chloride', 94, 'CH2'), ('CHEBI_20612', '5-methyltetrahydrofolate', 103, '5,10-methylenetetrahydrofolate'), ('CHEBI_65934', 'furowanin B', 135, '5-CH3'), ('CHEBI_20612', '5-methyltetrahydrofolate', 146, '5-methyltetrahydrofolate'), ('CHEBI_17478', 'aldehyde', 186, 'aldehyde'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 224, 'homocysteine'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 259, 'CBS'), ('CHEBI_15354', 'choline', 299, 'choline'), ('GO_0005737', 'cytoplasm', 344, 'cytoplasmic'), ('CHEBI_28212', 'deethylatrazine', 393, 'dimethylglycine'), ('CHEBI_42098', 'digoxigenin', 424, 'DHF'), ('CHEBI_36263', 'hydrogenmolybdate', 429, 'dihydrofolate'), ('CHEBI_33974', 'magnesium(1+)', 450, 'dihydrofolatereductase'), ('CHEBI_73956', '(S)-2-chloropropanoic acid', 502, '2′-deoxyuridine'), ('CHEBI_37983', 'sulfur-35 atom', 541, '10'), ('CHEBI_42485', 'formyl group', 544, 'formyl'), ('CHEBI_67016', 'tetrahydrofolate', 551, 'tetrahydrofolate'), ('CHEBI_19641', '2-hydroxyisobutyrate', 588, '10-formyl-tetrahydrofolate'), ('GO_0051318', 'G1 phase', 667, 'GNMT'), ('CHEBI_37958', 'dye', 703, 'Hcy'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 708, 'homocysteine'), ('GO_0005739', 'mitochondrion', 808, 'mitochondrial'), ('CHEBI_20612', '5-methyltetrahydrofolate', 861, '5,10-methylenetetrahydrofolate'), ('CHEBI_495055', 'beta-cyclodextrin', 892, 'cyclohydrolase'), ('CHEBI_52071', 'dextran', 915, '5,'), ('CHEBI_18123', 'N-methylnicotinate', 917, '10-methylenetetrahydrofolate'), ('CHEBI_18123', 'N-methylnicotinate', 970, '10-methylenetetrahydrofolate'), ('CHEBI_59650', 'amino fatty acid', 1075, '-adenosyl homocysteine'), ('CHEBI_17575', 'S-(5-deoxy-D-ribos-5-yl)-L-homocysteine', 1105, 'S -adenosyl homocysteine'), ('CHEBI_50770', 'N,N-dihydroxypentahomomethionine', 1146, 'S -adenosyl methionine'), ('PR_000014759', 'protein SCAF11', 1170, 'Sarc'), ('PR_000002097', 'sodium channel protein type 11 subunit alpha', 1176, 'sarcosine'), ('CHEBI_8984', 'sodium dodecyl sulfate', 1187, 'SDH'), ('CHEBI_67016', 'tetrahydrofolate', 1235, 'tetrahydrofolate')]
S50-PMC3322122	PMC3322122	4/2012	S50-PMC3322122	['of Genes involvedgenes involved in pathway94 dpcactin Cytoskeleton signalingup1.02*e-27Acta1, Cdc42, Msn, Rdx, Ssh2, Ttn, Vclg1/s checkpoint Regulationup2.48*e-23cdk6, E2F2, Hdac6Cyclin and Cell Cycle Regulationup1.19*e-24cdk6, E2F2, Hdac6, Ppp2R1Aorganisation of filamentsup1.53*e-48col1a1, Col1A2, Col5A1, lox, Msn, Nck2, rdx, Rhob1 dpnorganisation of filamentsup1.03*e-710akap2, Col1A1, Col1A2, Col5A1, Col5A2, Dcn, Fn1, lox, P4Ha1, Serpinh128 dpn-----188 dpn-----\nup and down indicate higher and lower abundance in hp compared to ap, respectively.']	N/A	N/A	[('SO_0000704', 'gene', 3, 'genes'), ('GO_0005856', 'cytoskeleton', 54, 'cytoskeleton'), ('PR_000010090', 'protein MAK10', 85, '27ACTA1'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 94, 'CDC42'), ('PR_000010718', 'metal-response element-binding transcription factor 2', 101, 'MSN'), ('PR_000013890', 'arginine-glutamic acid dipeptide repeats protein', 106, 'RDX'), ('PR_000015693', 'suppressor of tumorigenicity 7 protein', 111, 'SSH2'), ('PR_000016850', 'tyrosine-protein kinase TXK', 117, 'TTN'), ('PR_000017279', 'testis-specific basic protein Y 1', 122, 'VCLG1'), ('PR_000013990', 'rhophilin-1', 141, 'regulationup2'), ('PR_000006853', 'transcription factor E2F2', 168, 'E2F2'), ('PR_000008453', 'hepatitis A virus cellular receptor 1', 174, 'HDAC6Cyclin'), ('GO_0070370', 'cellular heat acclimation', 190, 'cell cycle regulationup1'), ('PR_000006853', 'transcription factor E2F2', 228, 'E2F2'), ('PR_000008488', 'histone deacetylase 9', 234, 'HDAC6'), ('PR_000013433', 'parathyroid hormone-related protein', 241, 'PPP2R1AOrganisation'), ('PR_000003266', 'collagen type II alpha chain', 292, 'COL1A2'), ('PR_000003266', 'collagen type II alpha chain', 300, 'COL5A1'), ('PR_000010718', 'metal-response element-binding transcription factor 2', 313, 'MSN'), ('PR_000011040', 'nuclear receptor coactivator 1', 318, 'NCK2'), ('PR_000013939', 'Ral-GDS-related protein', 329, 'RHOB1'), ('PR_000003266', 'collagen type II alpha chain', 382, 'COL1A1'), ('PR_000003266', 'collagen type II alpha chain', 390, 'COL1A2'), ('PR_000003266', 'collagen type II alpha chain', 398, 'COL5A1'), ('PR_000005703', 'collagen alpha-1(XIX) chain', 406, 'COL5A2'), ('PR_000006317', 'mRNA-decapping enzyme 1A', 414, 'DCN'), ('PR_000007581', 'fibronectin', 419, 'FN1'), ('PR_000012190', 'P2X purinoceptor 3', 429, 'P4HA1'), ('PR_000014660', 'septin-8', 436, 'SERPINH128')]
S112-PMC3156909	PMC3156909	9/2011	S112-PMC3156909	['lipistase did not inhibit Genes involved in Adipocyte differentiation (Pparγ2; Ccaat/Enhancer Binding Protein Α, Cebpα; Lipoprotein Lipase, Lpl), with the exception of Adipocyte Protein 2 (Ap2/Fabp4), which was reduced ( figure\xa04b ).']	N/A	N/A	[('SO_0000704', 'gene', 26, 'genes'), ('CL_0000136', 'fat cell', 44, 'adipocyte'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 71, 'PPARγ2'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 79, 'CCAAT/enhancer binding protein α'), ('SO_0000165', 'enhancer', 85, 'enhancer'), ('PR_000005311', 'CCAAT/enhancer-binding protein gamma', 113, 'CEBPα'), ('PR_000003659', 'long-chain-fatty-acid--CoA ligase 1', 120, 'lipoprotein lipase'), ('PR_000009880', 'Lon protease, mitochondrial', 140, 'LPL'), ('CL_0000136', 'fat cell', 168, 'adipocyte'), ('PR_000004519', 'autism susceptibility gene 2 protein', 168, 'adipocyte protein 2'), ('PR_000004123', 'adenomatous polyposis coli protein 2', 189, 'aP2'), ('PR_000007380', 'putative F-box/LRR-repeat protein 21', 193, 'FABP4')]
S63-PMC3342123	PMC3342123	3/2012	S63-PMC3342123	['of Regulated Genesgenes involved in pathway94 dpcwnt signalingup1.20*e-29acvr1, Csnk1G3, Fzd4, Fzd6, Map3K7, Mmp7, Tcf4, Tcf7L2, Wnt5Amitotic roles of Polo-Like Kinasedown5.15*e-811ccnb1, Ccnb2, Cdc23, Cdc25B, Cdk1, Fzr1, Sp90Aa1, Kif11, Plk1, Ppp2R1B, Pttg1G1/s Checkpoint Regulationdown2.76*e-58Ccnd2, Ccnd3, Ccne1, Cdk4, E2F1, E2F4, Rb1, Tfdp1G2/m dna damage Checkpoint Regulationdown1.53*e-35Ccnb1, Ccnb2, Cdc25B, Cdk1, Plk11 dpn-----28 dpncomplement systemup2.07*e-55c4b, c5, c6, c9, Cd55G1/s Checkpoint Regulationdown2.49*e-23cdkn1b, Hdac11, tgfb3188 dpnvegf signalingup2.80*e-412acta2, Akt3, Bcl2, Eif2B1, Kdr, Mapk1, mras, Pik3R3, Prkcb, Rras2, Vcl, vegfcmtor signalingup6.29*e-313Akt3, Eif3B, Eif4B, Mapk1, mras, Pik3R3, Ppp2Cb, Prkab2, Prkcb, Rhoj, Rras2, Tsc1, vegfcsynthesis and Degradation Of Ketone Bodiesup1.18*e-34acaa1, Bdh1, hadha, hadhbbile Acid Synthesisup3.33*e-37acaa1, adh5, Adhfe1, Aldh7A1, hadha, hadhb, lipafatty Acid Elongation in Mitochondriaup4.81*e-34acaa1, auh, hadha, hadhbglucocorticoid receptor signalingup3.99*e-217Akt3, Bcl2, Ccl2, Gtf2A2, Gtf2B, Gtf2E2, Hsp90Ab1, Hspa1B, Il1Rn, Mapk1, mras, Ncor1, Pbx1, Pik3R3, Rras2, Taf4, Vcam1Val, leu, ile degradationup8.32*e-38acaa1, Acad10, Aldh7A1, auh, bckdhb, hadha, hadhb, hibadhbiosynthesis Of Steroidsdown7.65*e-35cyp24a1, Cyp7B1, dhcr7, Fdft1, mvd\nthe comparison between the dietary Gestational protein diets (lp vs. ap) is shown in dependence of the Regulatory direction (up or down).']	N/A	N/A	[('GO_0065007', 'biological regulation', 3, 'regulated'), ('SO_0000704', 'gene', 13, 'genesGenes'), ('PR_000005920', 'lambda-crystallin', 80, 'CSNK1G3'), ('PR_000007719', 'frizzled-2', 89, 'FZD4'), ('PR_000007719', 'frizzled-2', 95, 'FZD6'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 101, 'MAP3K7'), ('PR_000010482', 'matrix metalloproteinase-23', 109, 'MMP7'), ('PR_000016190', 'trichohyalin-like protein 1', 115, 'TCF4'), ('PR_000016139', 'TATA box-binding protein-like 2', 121, 'TCF7L2'), ('PR_000017403', 'Wee1-like protein kinase', 129, 'WNT5AMitotic'), ('PR_000013440', 'protein tyrosine phosphatase type IVA 1', 151, 'Polo-like kinasedown5'), ('PR_000005155', 'T-complex protein 1 subunit zeta-2', 188, 'CCNB2'), ('PR_000005159', 'scavenger receptor cysteine-rich type 1 protein M160', 195, 'CDC23'), ('PR_000005205', 'serine/threonine-protein kinase MRCK alpha', 202, 'CDC25B'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 210, 'CDK1'), ('PR_000001445', 'discoidin domain-containing receptor 1', 216, 'FZR1'), ('PR_000015514', 'Msx2-interacting protein', 222, 'SP90AA1'), ('PR_000009291', 'kinesin-like protein KIF17', 231, 'KIF11'), ('PR_000012888', 'phospholipid transfer protein', 238, 'PLK1'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 244, 'PPP2R1B'), ('PR_000013440', 'protein tyrosine phosphatase type IVA 1', 253, 'PTTG1G1'), ('GO_0000724', 'double-strand break repair via homologous recombination', 263, 'checkpoint regulationdown2'), ('PR_000011040', 'nuclear receptor coactivator 1', 295, '58CCND2'), ('PR_000005155', 'T-complex protein 1 subunit zeta-2', 304, 'CCND3'), ('PR_000005155', 'T-complex protein 1 subunit zeta-2', 311, 'CCNE1'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 318, 'CDK4'), ('PR_000006852', 'transcription factor E2F1', 324, 'E2F1'), ('PR_000006854', 'transcription factor E2F3', 330, 'E2F4'), ('PR_000013830', 'calcipressin-2', 336, 'RB1'), ('PR_000016263', 'transcription factor AP-2-alpha', 341, 'TFDP1G2'), ('GO_0010031', 'circumnutation', 362, 'checkpoint regulationdown1'), ('PR_000010978', 'nucleosome assembly protein 1-like 4', 394, '35CCNB1'), ('PR_000005155', 'T-complex protein 1 subunit zeta-2', 403, 'CCNB2'), ('PR_000005205', 'serine/threonine-protein kinase MRCK alpha', 410, 'CDC25B'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 418, 'CDK1'), ('PR_000012898', 'plexin-B3', 424, 'PLK11'), ('PR_000005170', 'CD37 molecule', 489, 'CD55G1'), ('GO_0000724', 'double-strand break repair via homologous recombination', 498, 'checkpoint regulationdown2'), ('PR_000008478', 'histone deacetylase 1', 540, 'HDAC11'), ('PR_000003880', 'GTP:AMP phosphotransferase, mitochondrial', 593, 'AKT3'), ('PR_000004698', 'Bcl-2-like protein 2', 599, 'BCL2'), ('PR_000006970', 'protein argonaute-4', 605, 'EIF2B1'), ('PR_000009225', 'junctophilin-4', 613, 'KDR'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 618, 'MAPK1'), ('PR_000012727', 'phosphoinositide 3-kinase regulatory subunit 4', 631, 'PIK3R3'), ('PR_000013502', 'parvalbumin alpha', 639, 'PRKCB'), ('PR_000014318', 'radical S-adenosyl methionine domain-containing protein 2', 646, 'RRAS2'), ('PR_000017279', 'testis-specific basic protein Y 1', 653, 'VCL'), ('PR_000008770', 'corticosteroid 11-beta-dehydrogenase isozyme 1', 686, '313AKT3'), ('PR_000006979', 'eukaryotic translation initiation factor 3 subunit G', 695, 'EIF3B'), ('PR_000006979', 'eukaryotic translation initiation factor 3 subunit G', 702, 'EIF4B'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 709, 'MAPK1'), ('PR_000012727', 'phosphoinositide 3-kinase regulatory subunit 4', 722, 'PIK3R3'), ('PR_000013130', 'protein phosphatase 1 regulatory subunit 7', 730, 'PPP2CB'), ('PR_000013222', 'cAMP-dependent protein kinase catalytic subunit alpha', 738, 'PRKAB2'), ('PR_000013502', 'parvalbumin alpha', 746, 'PRKCB'), ('PR_000014009', 'regulating synaptic membrane exocytosis protein 1', 753, 'RHOJ'), ('PR_000014318', 'radical S-adenosyl methionine domain-containing protein 2', 759, 'RRAS2'), ('PR_000016770', 'testis-specific serine/threonine-protein kinase 1', 766, 'TSC1'), ('GO_0009600', 'detection of nematode', 791, 'degradation of ketone'), ('CHEBI_17087', 'ketone', 806, 'ketone'), ('PR_000002318', 'caspase-9', 813, 'bodiesup1'), ('PR_000004716', 'brain-derived neurotrophic factor', 837, 'BDH1'), ('CHEBI_37527', 'acid', 860, 'acid'), ('GO_0030534', 'adult behavior', 860, 'acid synthesisup3'), ('PR_000003773', 'all-trans-retinol dehydrogenase [NAD(+)] ADH7', 898, 'ADHFE1'), ('PR_000003932', '2-aminomuconic semialdehyde dehydrogenase', 906, 'ALDH7A1'), ('CHEBI_37527', 'acid', 939, 'acid'), ('GO_0046648', 'positive regulation of gamma-delta T cell proliferation', 939, 'acid elongation'), ('GO_0005759', 'mitochondrial matrix', 958, 'mitochondriaup4'), ('PR_000010405', 'MHC class I polypeptide-related sequence B', 1047, '217AKT3'), ('PR_000004698', 'Bcl-2-like protein 2', 1056, 'BCL2'), ('PR_000001204', 'C-C chemokine receptor type 8', 1062, 'CCL2'), ('PR_000008300', 'glutathione S-transferase mu 1', 1068, 'GTF2A2'), ('PR_000008311', 'TFIIA-alpha and beta-like factor', 1076, 'GTF2B'), ('PR_000008322', 'general transcription factor II-I', 1083, 'GTF2E2'), ('PR_000008820', 'heat shock protein beta-8', 1091, 'HSP90AB1'), ('PR_000008812', 'heat shock cognate 71 kDa protein', 1101, 'HSPA1B'), ('PR_000001386', 'interleukin-27 subunit beta', 1109, 'IL1RN'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 1116, 'MAPK1'), ('PR_000011209', 'nidogen-2', 1129, 'NCOR1'), ('PR_000012522', 'all trans-polyprenyl-diphosphate synthase PDSS2', 1136, 'PBX1'), ('PR_000012727', 'phosphoinositide 3-kinase regulatory subunit 4', 1142, 'PIK3R3'), ('PR_000014318', 'radical S-adenosyl methionine domain-containing protein 2', 1150, 'RRAS2'), ('PR_000016022', 'TATA box-binding protein-associated factor RNA polymerase I subunit C', 1157, 'TAF4'), ('PR_000014409', 'protein S100-A2', 1163, 'VCAM1Val'), ('PR_000029266', 'alkylglycerol monooxygenase', 1211, 'ACAD10'), ('PR_000003932', '2-aminomuconic semialdehyde dehydrogenase', 1219, 'ALDH7A1'), ('GO_0007007', 'inner mitochondrial membrane organization', 1274, 'of steroidsdown7'), ('CHEBI_66479', 'siamenol', 1277, 'steroidsdown7'), ('PR_000006101', 'cytochrome P450 1A1', 1307, 'CYP7B1'), ('PR_000007416', 'F-box only protein 48', 1322, 'FDFT1'), ('GO_0007565', 'female pregnancy', 1368, 'gestational'), ('GO_0065007', 'biological regulation', 1436, 'regulatory')]
S22-PMC4208652	PMC4208652	6/2014	S22-PMC4208652	"[""Cpg Islands in Human height‐associated Gene Promoters.Genes refseq numberchromosometss (nt)upstream tss1cpg islands% g+cobscpg/expcpglength (nt)Genome sequence assemblynt upstream tssnotes25' (nt)3' (nt) acan (weedon et al.2008; cho et al.2009)nm_0132271587147678165.70.7214858714679087148274888‡ Adamtsl3 (gudbjartsson et al.2008; lettre et al.2008; weedon et al.2008)nm_2075171582113842168,70,8219748211307682115050766‡ Adamts17 (gudbjartsson et al.2008)nm_1390571598699706260,70,65888990837399074858667*69,10,8920269870032398698297617‡ Agpat6 (lettre et al.2008)nm_178819841554876none Anapc13 (weedon et al.2008)nm_1553913135687519159,20,7881548135688471135686923952‡ Anks1 (gudbjartsson et al.2008)nm_0152456349650162550,80660349633552349634012166461,70,7814973496451934966016497‡ Atad5 (gudbjartsson et al.2008)nm_0248571726183149262,60,78136826175115261764838031*56,30,8129802618282626183806320‡ Atxn3 (gudbjartsson et al.2008)nm_0306601491642718160,40,74412269164322391641997516‡ Bcas3 (gudbjartsson et al.2008; cho et al.2009)nm_00109943217561099542550,7082056104151561049715803*59,50,6510585610936656110424588‡ Bmp2 (gudbjartsson et al.2008)nm_001200206696745166,70,95198866957596696745986‡ Bmp6 (gudbjartsson et al.2008)nm_00171867672010166,80,872687767090476735911106‡ Cables1 (gudbjartsson et al.2008)nm_0011074041818969725167,40,95262018968684189713041041‡ Cdk6 (gudbjartsson et al.2008; lettre et al.2008; weedon et al.2008)nm_001259792301148261,20,74827689230452792301759337962,10,81919519230175992299808611‡ Centa2 (gudbjartsson et al.2008)nm_0184041726272880255,10,6953226263024262635569856*65,90,7416872627261126274298269‡ Chchd7 (gudbjartsson et al.2008; lettre et al.2008)nm_024300857286869163,70,893197057285833572878031036‡ coil (gudbjartsson et al.2008)nm_0046451752393410156,30,77214045239368552392281275‡ Cpsf2 (gudbjartsson et al.2008)nm_17580813916580901580,8212991656710916588391372‡ Crlf3 (gudbjartsson et al.2008)nm_0159861726175904255,90,817108426183907261828238003*62,60,77513682617648026175112576‡ dcc (lettre et al.2008)nm_0052151848120569153,90,66132448121704813494399‡ def6 (gudbjartsson et al.2008)nm_022047635373573none dgke (gudbjartsson et al.2008)nm_0036471752266552166,70,88255452265265522678191287‡ dleu7 (weedon et al.2008)nm_1989891350315886166,40,65712175031634550315128459‡ Dnm3 (gudbjartsson et al.2008)nm_0155691170077261166,10,731498170076559170078057702‡ Dnmt3A (gudbjartsson et al.2008)nm_175629225342590179,20,80426122534022725342838248‡ Dot1L (lettre et al.2008)nm_0324821921151484550,685052108150210816556998*550,75498211021421107124934*56,10,6558621130682113654208065,30,86289121141842117075964‡ dym (weedon et al.2008)nm_0176531845241077160,20,80813974524158045240183503‡ Efemp1 (gudbjartsson et al.2008; weedon et al.2008; cho et al.2009)nm_004105256003860158,70,68313505600498156003631545‡ e4f1 (lettre et al.2008)nm_004424162213568264,30,922647220461022075278958*65,10,79151722127272214244841‡ Fbln5 (gudbjartsson et al.2008; lettre et al.2008)nm_0063291491483799157,20,7713579148439591483038607‡ Fbp2 (cho et al.2009)nm_003837.2997321226none Fubp3 (lettre et al.2008)nm_0039349132444781165,20,771356132444169132445525612‡ Gatad1 (gudbjartsson et al.2008)nm_021167791914701160,80,8014429191422791915669474‡ Glt25D2 (gudbjartsson et al.2008)nm_0151011182273486165,10,7711841182273758182271917272‡ Gna12 (gudbjartsson et al.2008)nm_00735372850485167,20,888155328511252849572640‡ Gpr126 (gudbjartsson et al.2008; lettre et al.2008)nm_0010323956142664749161,60,731488142663983142665471776‡ Grb10 (lettre et al.2008)nm_001001549750767544167,50,96519645082943650827472784‡ hhip (gudbjartsson et al.2008; lettre et al.2008; weedon et al.2008; cho et al.2009)nm_0224754145786623162,20,7018691457854711457873401152‡ Hist1H1D (lettre et al.2008)nm_0053206263431951550,66750026349982263494826787* Hmga1 (gudbjartsson et al.2008; cho et al.2009)nm_145899634312628167,60,79421234310234343144462394‡ Hmga2 (gudbjartsson et al.2008; lettre et al.2008; weedon et al.2008; cho et al.2009)nm_0034831264504507164,40,78313364503504645066371003‡ ihh (weedon et al.2008)nm_0021912219633433170,20,76519082196346552196327471222‡ lbh (gudbjartsson et al.2008)nm_030915630307901165,80,80196530306777303087421124‡ lcorl (gudbjartsson et al.2008; weedon et al.2008; cho et al.2009)nm_153686417632483163,80,887233917633555176312161078‡ Lin28B (lettre et al.2008)nm_0010043176105511616155,10,894901055074801055079703986 Ltbp1 (cho et al.2009)nm_206943.22452207165,20,9091292116500451165133710000* lyar (lettre et al.2008)nm_01781644342744161,90,69137943436864342307942‡ lyn (gudbjartsson et al.2008)nm_001111097856954940164,90,8118135695440356954926523‡ mos (gudbjartsson et al.2008)nm_0227468571890952550,9459805719388957192909399459,90,74711965718924957188053154‡ Mtmr11 (gudbjartsson et al.2008)nm_1818731148174867none Naca2 (gudbjartsson et al.2008)nm_1992901757023345none Ncapg (gudbjartsson et al.2008; cho et al.2009)nm_022346417421623159,30,8915741742088617422460737‡ nog (gudbjartsson et al.2008)nm_0054501752026059164,80,79298252024564520275461710‡ Nkx2‐1/Ttf1 (lettre et al.2008)nm_0033171436055353360,30,67166136064854360631935687*58,50,6511903606257436061384340759,40,729216336061089360589261922‡ Pappa (lettre et al.2008)nm_0025819117955892164,50,85137311795586911795724223‡ Penk (gudbjartsson et al.2008)nm_006211857521143257,80,6553657523392575228562249‡62,20,801236157522705575203441562‡ Pex1 (gudbjartsson et al.2008)nm_000466791995781159,10,92813569199636491995008583‡ Plagl1 (gudbjartsson et al.2008; cho et al.2009)nm_002655857286413163,70,893197057287800572858301408‡ Pnpt1 (gudbjartsson et al.2008)nm_033109255774515156,10,7889095577474155773832278‡ Prkg2 (lettre et al.2008)nm_0062594823452391570,6557482354957823535139718* ptch1 (weedon et al.2008; cho et al.2009)nm_001083605997319068163,60,85124119731996597317554897‡ Pxmp3 (gudbjartsson et al.2008)nm_001079867878075079158,60,7913037807593178074628852‡ Rab40C (lettre et al.2008)nm_02116816580180169,70,9127155782925810071885‡ Rbbp8 (gudbjartsson et al.2008)nm_2032911818767837158,70,9014761876679318768269500‡ Rdhe2 (gudbjartsson et al.2008; lettre et al.2008)nm_138969857395795none Rnf135 (gudbjartsson et al.2008)nm_1979391726322082159,20,7712342632170226322936380‡ Rps20 (gudbjartsson et al.2008)nm_001023857149623155,10,95110475715008457149037461‡ Scmh1 (weedon et al.2008)nm_012236141480375168,70,79819994148123441479235859‡ Scube3 (gudbjartsson et al.2008)nm_152753635290168163,10,77200335288777352907801391‡ Sf3B4 (gudbjartsson et al.2008)nm_0058501148166326156,10,651879148166783148165904457‡ Sh3Gl3 (lettre et al.2008)nm_0030271581907287162,60,7317738190648881908261799‡ Socs2 (gudbjartsson et al.2008; weedon et al.2008; cho et al.2009)nm_0038771292487729166,40,822790924876499249043980‡ Spag1 (weedon et al.2008; cho et al.2009)nm_0031148101239832158,10,771239101238989101240228450‡ Sv2A (gudbjartsson et al.2008)nm_0148491148156054none Tbx2 (gudbjartsson et al.2008)nm_0059941756832039167,30,81597456827581568335554458‡ Tbx4 (gudbjartsson et al.2008)nm_0010030061756888634367,10,74170056883545568852455044*62,30,8112985688629356887591229664,60,7215165688830456889820285‡ tcp11 (gudbjartsson et al.2008)nm_018679635217165167,10,71811343521761735216483452‡ Tgs1 (gudbjartsson et al.2008)nm_024831856848345159,50,814005684763556849035710‡ Tmed3 (lettre et al.2008)nm_0073641577390546166,80,7111337738998577391118561‡ Trim25 (gudbjartsson et al.2008)nm_0050821752346408163,60,75114605234706152345601653‡ Trip11 (gudbjartsson et al.2008; lettre et al.2008)nm_0042391491576570156,40,76813109157673291575422593‡ uqcc/Gdf5 (gudbjartsson et al.2008; lettre et al.2008; weedon et al.2008; cho et al.2009)nm_0182442033463247156,30,6517743346366933462895422‡ Wdr60 (lettre et al.2008)nm_018517158342030160,70,821440158341361158342801669‡ Zbtb38 (gudbjartsson et al.2008; lettre et al.2008; weedon et al.2008; cho et al.2009)nm_0010804123142525745none Zfhx4 (gudbjartsson et al.2008)nm_0247218777560703550,7854077748585777491257485*56,60,72106477752435777434993635550,855457775572677746271344‡ Znf76 (gudbjartsson et al.2008)nm_003427635335488164,50,7814903533450235335992986‡ Znf462 (gudbjartsson et al.2008)nm_0212249108665199255,40,721475108661904108663379329561,90,65507108664296108664803903 Znf678 (weedon et al.2008; cho et al.2009)nm_1785491225817867166,40,6613002258148641086661643003\nTss: Trascription Start Site.""]"	N/A	N/A	[('SO_0000307', 'CpG_island', 0, 'CpG islands'), ('NCBITaxon_9606', 'Homo sapiens', 15, 'human'), ('SO_0000704', 'gene', 39, 'gene'), ('SO_0000167', 'promoter', 44, 'promoters'), ('SO_0000704', 'gene', 54, 'Genes'), ('SO_0001026', 'genome', 144, 'Genome'), ('PR_000003739', 'ADAMTS-like protein 2', 297, 'ADAMTSL3'), ('PR_000003739', 'ADAMTS-like protein 2', 422, 'ADAMTS17'), ('PR_000003820', 'putative Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 7', 539, 'AGPAT6'), ('PR_000004051', 'ankyrin repeat and SAM domain-containing protein 1A', 588, 'ANAPC13'), ('PR_000004037', 'ankyrin repeat and KH domain-containing protein 1', 671, 'ANKS1'), ('PR_000029291', 'phospholipid-transporting ATPase IB', 785, 'ATAD5'), ('PR_000004405', 'activating transcription factor 7-interacting protein 1', 902, 'ATXN3'), ('PR_000004691', 'B-cell lymphoma/leukemia 11B', 987, 'BCAS3'), ('PR_000000164', 'BMP2', 1120, 'BMP2'), ('PR_000000168', 'BMP7', 1200, 'BMP6'), ('PR_000004968', 'calretinin', 1280, 'CABLES1'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 1370, 'CDK6'), ('PR_000005393', 'cingulin', 1524, 'CENTA2'), ('PR_000029353', 'centrosomal protein of 89 kDa', 1641, 'CHCHD7'), ('PR_000005800', 'carboxypeptidase A6', 1830, 'CPSF2'), ('PR_000005878', 'cysteine-rich secretory protein 1', 1912, 'CRLF3'), ('PR_000006564', 'dynein heavy chain 5, axonemal', 2321, 'DNM3'), ('PR_000006609', 'DNA (cytosine-5)-methyltransferase 3-like', 2406, 'DNMT3A'), ('PR_000006664', 'dipeptidyl peptidase 9', 2491, 'DOT1L'), ('PR_000006900', 'erythroid differentiation-related factor 1', 2729, 'EFEMP1'), ('PR_000007383', 'F-box/LRR-repeat protein 5', 2954, 'FBLN5'), ('PR_000007355', 'Fas-binding factor 1', 3057, 'FBP2'), ('PR_000007690', 'ferritin heavy chain', 3103, 'FUBP3'), ('PR_000029520', 'GRAM domain-containing protein 2B', 3183, 'GATAD1'), ('PR_000029511', 'GNAS gene translation product', 3267, 'GLT25D2'), ('PR_000008080', 'guanine nucleotide-binding protein subunit alpha-11', 3356, 'GNA12'), ('PR_000001510', 'probable G-protein coupled receptor 148', 3437, 'GPR126'), ('PR_000008210', 'glutathione peroxidase 1', 3546, 'GRB10'), ('PR_000008593', 'histone H2B type 1-M', 3767, 'HIST1H1D'), ('PR_000008608', 'hexokinase-1', 3846, 'HMGA1'), ('PR_000008608', 'hexokinase-1', 3946, 'HMGA2'), ('PR_000009800', 'DNA ligase 1', 4367, 'LIN28B'), ('PR_000009878', 'BLOC-1-related complex subunit 5', 4450, 'LTBP1'), ('PR_000010754', 'mitochondrial tumor suppressor 1', 4796, 'MTMR11'), ('PR_000011050', 'kinetochore protein NDC80', 4852, 'NACA2'), ('PR_000011009', 'neuroblastoma-amplified sequence', 4907, 'NCAPG'), ('PR_000011242', 'homeobox protein Nkx-2.2', 5089, 'NKX2'), ('PR_000003770', 'all-trans-retinol dehydrogenase [NAD(+)] ADH4', 5094, '1'), ('PR_000016770', 'testis-specific serine/threonine-protein kinase 1', 5096, 'TTF1'), ('PR_000012271', 'pappalysin-2', 5240, 'PAPPA'), ('PR_000012527', 'Na(+)/H(+) exchange regulatory cofactor NHE-RF4', 5319, 'PENK'), ('PR_000012566', 'PEX5-related protein', 5435, 'PEX1'), ('PR_000012889', 'BPI fold-containing family A member 1', 5518, 'PLAGL1'), ('PR_000013050', 'suppressor of SWI4 1', 5620, 'PNPT1'), ('PR_000013222', 'cAMP-dependent protein kinase catalytic subunit alpha', 5703, 'PRKG2'), ('PR_000013270', 'pyridoxal phosphate homeostasis protein PLPBP', 5875, 'PXMP3'), ('PR_000013610', 'Ras-related protein Rab-34', 5961, 'RAB40C'), ('PR_000013790', 'RNA-binding protein 25', 6035, 'RBBP8'), ('PR_000013829', 'calcipressin-1', 6119, 'RDHE2'), ('PR_000014090', 'E3 ubiquitin-protein ligase RNF146', 6192, 'RNF135'), ('PR_000014290', '40S ribosomal protein S7', 6277, 'RPS20'), ('PR_000002099', 'sodium channel protein type 3 subunit alpha', 6361, 'SCMH1'), ('PR_000014555', 'syntenin-2', 6439, 'SCUBE3'), ('PR_000014747', 'secreted frizzled-related protein 5', 6524, 'SF3B4'), ('PR_000014823', 'endophilin-A2', 6610, 'SH3GL3'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 6689, 'SOCS2'), ('PR_000015479', 'spermatogenesis-associated protein 12', 6807, 'SPAG1'), ('PR_000015693', 'suppressor of tumorigenicity 7 protein', 6903, 'SV2A'), ('PR_000016129', 'tubulin-specific chaperone E', 6957, 'TBX2'), ('PR_000016137', 'TATA-box-binding protein', 7041, 'TBX4'), ('PR_000016299', 'trans-Golgi network integral membrane protein 2', 7276, 'TGS1'), ('PR_000029805', 'transmembrane protein 214', 7357, 'TMED3'), ('PR_000016662', 'tripartite motif-containing protein 55', 7435, 'TRIM25'), ('PR_000016663', 'E3 ubiquitin-protein ligase TRIM63', 7521, 'TRIP11'), ('PR_000007948', 'GDNF family receptor alpha-1', 7631, 'GDF5'), ('PR_000029867', 'WD repeat-containing protein 72', 7768, 'WDR60'), ('PR_000017593', 'zinc finger and BTB domain-containing protein 7B', 7847, 'ZBTB38'), ('PR_000017622', 'AN1-type zinc finger protein 2B', 7960, 'ZFHX4'), ('PR_000018128', 'zinc finger protein 75D', 8102, 'ZNF76'), ('PR_000017889', 'zinc finger protein 430', 8185, 'ZNF462'), ('PR_000018050', 'zinc finger protein 644', 8304, 'ZNF678'), ('SO_0001434', 'cassette_pseudogene', 8401, 'TSS'), ('SO_0000315', 'TSS', 8406, 'trascription start site')]
S126-PMC4132016	PMC4132016	8/2014	S126-PMC4132016	['*p≤0.05.10.1371/journal.pone.0104896.t001\n\ncaption (table-wrap): table 1\nphysiological parameters.f1-Cdf1-lpdp-valueglucose (mg/dl)89.13±9.0763.57±8.990.026insulin (ng/ml)0.463±0.0340.167±0.0067.6×10−09tg (mm)0.564±0.0240.381±0.0231.43×10−06cholesterol (mm)3.376±0.0123.431±0.0120.0023cholesterol-hdl (mm)0.752±0.0190.78±0.024ns\nPlasma Metabolites and hormones parameters of 7-mo-old male f1-cd and f1-lpd Mice were measured in Plasma of over-night starved Animals and are expressed as means ±semfor n\u200a=\u200a10 (Glucose) or n\u200a=\u200a25 (Insulin, tg, Cholesterol, Cholesterol-hdl).']	N/A	N/A	[('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 101, 'CDF1'), ('UBERON_0001969', 'blood plasma', 329, 'Plasma'), ('CHEBI_25212', 'metabolite', 336, 'metabolites'), ('NCBITaxon_10088', 'Mus <genus>', 406, 'mice'), ('UBERON_0001969', 'blood plasma', 428, 'plasma'), ('NCBITaxon_33208', 'Metazoa', 457, 'animals'), ('CHEBI_17234', 'glucose', 508, 'Glucose'), ('PR_000045358', 'insulin family protein', 528, 'Insulin'), ('CHEBI_16113', 'cholesterol', 541, 'Cholesterol'), ('CHEBI_16113', 'cholesterol', 554, 'Cholesterol')]
S203-PMC5069446	PMC5069446	10/2016	S203-PMC5069446	['additionally, maternal protein restriction during Gestation increases the Expression of Ccaat/Enhancer-Binding Protein (C/Ebpβ) and Glucose Transporter 4 (Glut4) in female offspring Rat Skeletal muscle through the Regulation Of Histone Modification at their Promoter regions152,153.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 50, 'gestation'), ('GO_0010467', 'gene expression', 74, 'expression'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 88, 'CCAAT/enhancer-binding protein'), ('SO_0000165', 'enhancer', 94, 'enhancer'), ('PR_000004967', 'calbindin', 120, 'C/EBPβ'), ('CHEBI_17234', 'glucose', 132, 'glucose'), ('PR_000015064', 'solute carrier family 2, facilitated glucose transporter member 2', 132, 'glucose transporter 4'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 155, 'GLUT4'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 182, 'rat'), ('UBERON_0004288', 'skeleton', 186, 'skeletal'), ('GO_0007565', 'female pregnancy', 214, 'regulation of'), ('CHEBI_15358', 'histone', 228, 'histone'), ('GO_0016570', 'histone modification', 228, 'histone modification'), ('PR_000043452', 'core histone', 228, 'histone'), ('SO_0000167', 'promoter', 258, 'promoter')]
